<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">EMR</journal-id>
<journal-id journal-id-type="hwp">spemr</journal-id>
<journal-title>Emotion Review</journal-title>
<issn pub-type="ppub">1754-0739</issn>
<issn pub-type="epub">1754-0747</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1754073911421374</article-id>
<article-id pub-id-type="publisher-id">10.1177_1754073911421374</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Elevated Plus-Maze Test: Differential Psychopharmacology of Anxiety-Related Behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pawlak</surname><given-names>Cornelius R.</given-names>
</name>
</contrib>
<aff id="aff1-1754073911421374">Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany</aff>
<aff id="aff2-1754073911421374">Chair of Biological and Clinical Psychology, School of Social Sciences, University of Mannheim, Germany</aff>
<aff id="aff3-1754073911421374">Institute of Psychology, University of Frankfurt am Main, Germany</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Karrenbauer</surname><given-names>Britta D.</given-names></name>
</contrib>
<aff id="aff4-1754073911421374">Department of Experimental and Physiological Psychology, Philipps-University of Marburg, Germany</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Schneider</surname><given-names>Peggy</given-names></name>
</contrib>
<aff id="aff5-1754073911421374">Department of Psychopharmacology, Central Institute of Mental Health, Germany</aff>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ho</surname><given-names>Ying-Jui</given-names></name>
</contrib>
<aff id="aff6-1754073911421374">School of Psychology, Chung Shan Medical University, Taiwan, ROC</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1754073911421374">Cornelius R. Pawlak, Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, J 5, 68159 Mannheim, Germany. <italic>Email</italic>: <email>cornelius.pawlak@zi-mannheim.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>4</volume>
<issue>1</issue>
<fpage>98</fpage>
<lpage>115</lpage>
<permissions>
<copyright-statement>© ISRE and SAGE 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">ISRE and SAGE</copyright-holder>
</permissions>
<abstract>
<p>The role of individual factors in behavioral neuroscience is an important, but still neglected, area of research. For example, the Elevated Plus-Maze Test has been one of the most used paradigms to gauge unconditioned aversively motivated behavior in rodents. However, despite a great number of experiments with this test there have been only few efforts to assess systematic individual variations in the elevated plus-maze and related neurobiological functions. The present review aims to give, first, a general overview and introduction about the test, and second, an animal model of anxiety based on natural variance of plus-maze behavior within a given unselected population of rats. Finally, critical aspects of such approaches in animal research are discussed, and suggestions are given as to where to go from here.</p>
</abstract>
<kwd-group>
<kwd>anxiety</kwd>
<kwd>avoidance behavior</kwd>
<kwd>basal ganglia</kwd>
<kwd>differential psychopharmacology</kwd>
<kwd>emotion</kwd>
<kwd>exploration behavior</kwd>
<kwd>fear</kwd>
<kwd>high open arm (HOA)</kwd>
<kwd>individuality</kwd>
<kwd>low open arm (LOA)</kwd>
<kwd>motivation</kwd>
<kwd>one-trial tolerance</kwd>
<kwd>personality</kwd>
<kwd>striatum</kwd>
<kwd>traits</kwd>
<kwd>translational</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The role of individual difference factors in behavioral neuroscience is an important, but still neglected, area of research. One problem is the need for higher numbers of participants or subjects than the commonly used approach. Accordingly, research issues requiring many subjects (e.g., dose–response effects) are often neglected in favor of less laborious inquiries. In recent years, however, the necessity of an individual approach for research on biology–behavior relationships has become more and more important (<xref ref-type="bibr" rid="bibr102-1754073911421374">Mehta &amp; Gosling, 2008</xref>; <xref ref-type="bibr" rid="bibr112-1754073911421374">Pawlak, Ho, &amp; Schwarting, 2008</xref>). Despite the progress in examining biopsychological processes in humans, behavioral neuroscience in animals remains indispensable. For example, do animals show substantial differences in behavior, physiology, or pharmacological reactivity? What are the relationships between these parameters and how consistent are they? What are the key domains of individual behavioral differences that have physiological relevance? More importantly, can these domains predict a priori the outcome of experimental manipulations? To what extent do certain stable characteristics of the organism shape physiological outcomes, before and after experimental manipulations? Data on animals’ individual behavior and physiological functions could be important for the further understanding of psychiatric disorders by individual personality dimensions (<xref ref-type="bibr" rid="bibr84-1754073911421374">Khan, Jacobson, Gardner, Prescott &amp; Kendler, 2005</xref>). It may be reasonable for personality researchers to accept animal research to tackle questions on personality that are difficult or impossible to address by human studies solely. Already <xref ref-type="bibr" rid="bibr71-1754073911421374">Hebb (1949)</xref>, Pavlov (summarized by <xref ref-type="bibr" rid="bibr156-1754073911421374">Strelau, 1997</xref>) and <xref ref-type="bibr" rid="bibr180-1754073911421374">Yerkes and Yerkes (1936)</xref> have performed comparative studies of personality in animals. However, there is no uniform framework for comparative research specifying how animal studies can contribute to personality research (<xref ref-type="bibr" rid="bibr60-1754073911421374">Gosling, 2001</xref>).</p>
<p>The present review aims to give, first, a general overview and introduction about the elevated plus maze test which is one of the most often used paradigms to gauge unconditioned avoidance–approach behavior (<xref ref-type="bibr" rid="bibr167-1754073911421374">Walf &amp; Frye, 2007</xref>). Second, we introduce the concept of an animal model of anxiety-like behavior based on natural variance within a given population. Finally, critical aspects of such approaches in animal research are discussed, and suggestions for where to go from here are given.</p>
<sec id="section1-1754073911421374">
<title>Rationale, Set-Up, Procedure</title>
<p>Originally, a so-called symmetrically elevated Y maze was created for rats by <xref ref-type="bibr" rid="bibr105-1754073911421374">Montgomery (1955)</xref>. This test was further modified by <xref ref-type="bibr" rid="bibr119-1754073911421374">Pellow, Chopin, File, and Briley (1985)</xref> into what is now known as the elevated plus-maze. The assumption in this paradigm is that the natural exploratory behavior of rats is suppressed under certain conditions (e.g., elevation, open space), causing an approach–avoidance conflict. The elevated plus-maze is assumed to gauge unconditioned anxiety-like behavior or, expressed in more specific behavioral terms, unconditioned avoidance behavior, which has been extensively used as an animal model for anxiety. During a typical Elevated Plus-Maze Test, animals will actively avoid the open arms in favor of the closed arms. During a retest, animals avoid the open arms more than during the first exposition, which may reflect a fear-like response. A corresponding apparatus was developed for mice by <xref ref-type="bibr" rid="bibr92-1754073911421374">Lister (1987)</xref>.</p>
<p>A typical rat maze has four arms arranged as a plus and is commonly elevated at a height of approximately 50 cm. The closed parts consist of two opposite arms provided with side walls (approximately 40 cm high), whereas the two opposite open arms have no side walls. All four arms have a length usually of 50 cm each, and a width usually of 10 cm. The middle section, that allows the animal to transit from arm to arm, consists of a square with dimensions usually of 10 × 10 cm. The apparatus is often made of grey plastic (sometimes the open arms do have opaque walls), or wood. The open arms can be modified to prevent animals from falling off, by a small raised edge surrounding the open arms, or a rough surface. The animal is then able to get a grip with its claws.</p>
<p>At the start of testing, the animal is placed in the middle section and is often released towards an open or a closed arm. The animal may also be released between an open and closed arm (45° towards each arm), but regardless, the same procedure is used throughout a given experiment. The animal is then allowed to freely explore the elevated plus-maze for 5 minutes (sometimes 10 minutes or more have been used, but this may have dramatic behavioral effects on successive trials; see the section “The One-Trial Tolerance Effect”). The most important measure for anxiety-like/avoidance behavior is either the relative time spent on open arms expressed as the percentage from the sum of open plus closed arm time, or the total open arm time. Other measures used include total open arm time and total open arm entries separately, or the ratio of the number of entries into the open arms relative to all arm entries. Open arm time and open arm entries are usually highly correlated. In order to control for general activity, entries into the closed arms and entries into all arms are analyzed (<xref ref-type="bibr" rid="bibr45-1754073911421374">File, 2001</xref>). Anxiolytic-like/approach activity is attributed to a given test drug if the animal prefers the open arms without changing the number of closed arm entries compared to control rats (<xref ref-type="bibr" rid="bibr169-1754073911421374">Weiss, Wadsworth, Fletcher, &amp; Dourish, 1998</xref>). The processes mediating such avoidance–approach behavior are not clear, but it seems that either height and/or the open aspects of the arms may be critical (<xref ref-type="bibr" rid="bibr41-1754073911421374">Fernandes &amp; File, 1996</xref>; <xref ref-type="bibr" rid="bibr50-1754073911421374">File &amp; Zangrossi, 1993</xref>).</p>
<p>There are additional control issues to consider. When using a battery of tests, particularly if the tests are performed over a brief period of time, the sequence may be crucial. There is evidence that testing the animals in an open field (test paradigm which also evokes unconditioned aversive behavior) or with other apparatus, shortly before the elevated plus-maze, produces different results (<xref ref-type="bibr" rid="bibr134-1754073911421374">Rodgers &amp; Cole, 1993</xref>). Factors such as early handling of the animals (<xref ref-type="bibr" rid="bibr8-1754073911421374">Andrews &amp; File, 1993</xref>), environmental enrichment (<xref ref-type="bibr" rid="bibr138-1754073911421374">Santucci, Daud, Almeida, &amp; de Oliveira, 1994</xref>), or low illumination of the plus-maze (<xref ref-type="bibr" rid="bibr57-1754073911421374">Garcia, Cardenas, &amp; Morato, 2005</xref>) can decrease anxiety-like/avoidance behavior and thus change the reactivity to anxiolytic drugs (<xref ref-type="bibr" rid="bibr76-1754073911421374">Hogg, 1996</xref>; <xref ref-type="bibr" rid="bibr86-1754073911421374">Kõks et al., 2001</xref>). Further, age, sex, environment, experience, and the experimenter can exert strong influences (e.g., <xref ref-type="bibr" rid="bibr32-1754073911421374">Crabbe, Wahlsten, &amp; Dudek, 1999</xref>; <xref ref-type="bibr" rid="bibr153-1754073911421374">Steimer &amp; Driscoll, 2005</xref>; <xref ref-type="bibr" rid="bibr166-1754073911421374">Wahlsten et al., 2003</xref>). Finally, when tests are carried out at different times of the day/night cycle, there may be interference with circadian rhythms which would have to be taken into consideration (<xref ref-type="bibr" rid="bibr5-1754073911421374">Andrade, Tomé, Santiago, Lúcia-Santos, &amp; de Andrade, 2003</xref>).</p>
<p>But interestingly, there have been reports from the present laboratory showing no substantial differences in total open arm times and other behaviors for rats tested in the elevated plus-maze (and open field) comparing daytime (e.g., <xref ref-type="bibr" rid="bibr114-1754073911421374">Pawlak &amp; Schwarting, 2002</xref>) with night time (<xref ref-type="bibr" rid="bibr10-1754073911421374">Bauhofer et al., 2004</xref>), or after transient isolated housing beginning immediately after weaning (<xref ref-type="bibr" rid="bibr148-1754073911421374">Schwarting &amp; Pawlak, 2004</xref>). Finally, combined handling (i.e., picking up the animal) and gentling (i.e., gentle stroking to familiarize the animal with the experimenter more thoroughly than purpose-defined handling) did not affect open arm time or entries, but risk assessment (see following lines), in the elevated plus-maze (<xref ref-type="bibr" rid="bibr21-1754073911421374">Borta, Wöhr, &amp; Schwarting, 2006</xref>). There is also other evidence showing that elevated plus-maze behavior can also be relatively immune to certain test- or pretest conditions, including anxiogenic ones (<xref ref-type="bibr" rid="bibr57-1754073911421374">Garcia et al., 2005</xref>; <xref ref-type="bibr" rid="bibr165-1754073911421374">Vyas &amp; Chattarji, 2004</xref>), which may point at its usefulness to measure trait—rather than state—dependencies.</p>
</sec>
<sec id="section2-1754073911421374">
<title>Conflict between Approach and Avoidance Behavior</title>
<p>The elevated plus-maze is a conflict test in which novelty produces both approach (open arm) and avoidance (closed arm), interpreted as curiosity and anxiety or caution, respectively (<xref ref-type="bibr" rid="bibr68-1754073911421374">Handley &amp; McBlane, 1993</xref>). In a recent review, <xref ref-type="bibr" rid="bibr28-1754073911421374">Carobrez and Bertoglio (2005)</xref> summarize that the shift from exploratory to avoidance/anxiety-like behavior in the first trial occurs until the second minute, when roughly equal open and enclosed arm exploration are observed, suggesting novelty curiosity as the main motivational stimulus during this phase. As the session continues, however, rats show a pronounced preference for the closed arms. This approach–avoidance conflict is generated when the animal encounters a novel situation that creates ambiguity between motivated exploratory behavior and unconditioned anxiety-like/avoidance behavior towards novelty (<xref ref-type="bibr" rid="bibr110-1754073911421374">Ohl, 2003</xref>). This is the reason why it is appropriate to assess the total time in separate bins. Anxiolytic drugs can shift the balance of this conflict from avoidance towards approach (<xref ref-type="bibr" rid="bibr64-1754073911421374">Gray &amp; McNaughton, 2000</xref>). It is established that the increased tendency to avoid the open arms during minutes 3–5 can be prevented by anxiolytic drugs such as benzodiazepines (GABA<sub>A</sub> receptor agonist). Conversely, the predominance of approach during the initial 2 minutes can be blocked by anxiogenic drugs, causing increased avoidance of the open arms.</p>
<p>The conflict between approach and avoidance behavior is exemplified by the so-called “risk assessment” when the animal behaves ambiguously in its approach towards the open arms of an elevated plus-maze, which is discussed in the following text. Risk assessment behavior has been proposed to improve the validity of anxiety-like behavior in addition to the open arm time (<xref ref-type="bibr" rid="bibr28-1754073911421374">Carobrez &amp; Bertoglio, 2005</xref>).</p>
<sec id="section3-1754073911421374">
<title>Risk Assessment Behavior</title>
<p>In potentially dangerous situations (e.g., when a predator has been seen but is no longer present), laboratory rats (<xref ref-type="bibr" rid="bibr13-1754073911421374">Blanchard &amp; Blanchard, 1989</xref>) and mice (<xref ref-type="bibr" rid="bibr15-1754073911421374">Blanchard et al., 1995</xref>) have been reported to engage in a cluster of behavioral actions collectively referred to as risk assessment. <xref ref-type="bibr" rid="bibr133-1754073911421374">Rodgers, Cao, Dalvi, and Holmes (1997)</xref> summarize that these responses, originally identified in specially constructed visible burrow systems, are characterized by cautious approaches to an area where a predator (e.g., cat) has briefly been presented. Risk assessment includes (a) scanning the danger area from tunnel openings, (b) stretched attend or flat back postures directed towards the danger area, and (c) stretched or flat back locomotion upon initial reentry into the danger area (<xref ref-type="bibr" rid="bibr133-1754073911421374">Rodgers et al., 1997</xref>). Very similar behavior patterns have been observed in the rat defensive burying paradigm (another test of aversive motivated behavior; <xref ref-type="bibr" rid="bibr104-1754073911421374">Molewijk, van der Poel, &amp; Olivier, 1995</xref>; <xref ref-type="bibr" rid="bibr125-1754073911421374">Pinel &amp; Mana, 1989</xref>) and in mice exposed to conspecific odors (<xref ref-type="bibr" rid="bibr56-1754073911421374">Garbe &amp; Kemble, 1994</xref>; <xref ref-type="bibr" rid="bibr81-1754073911421374">Kaesermann, 1986</xref>), supporting the idea that the pattern may be of functional importance. Thus, common risk assessment behavior could reflect a comparable behavioral strategy in different potentially dangerous situations (<xref ref-type="bibr" rid="bibr14-1754073911421374">Blanchard &amp; Blanchard, 1990</xref>; <xref ref-type="bibr" rid="bibr16-1754073911421374">Blanchard, Yudko, Rodgers, &amp; Blanchard, 1993</xref>).</p>
</sec>
<sec id="section4-1754073911421374">
<title>Impulsivity</title>
<p>In spite of the emphasis on anxiety in the present studies (and in much of the literature) some data also point to another interesting and often neglected hypothesis: Rats with low avoidance behavior may not only be less anxious than high avoidance animals, but they may also be more impulsive, or novelty seeking, as postulated in a behavioral model based on evidence from studies with high- versus low-avoidance rats (summarized by <xref ref-type="bibr" rid="bibr152-1754073911421374">Steimer &amp; Driscoll, 2003</xref>).</p>
<p>The relationship between anxiety-like/avoidance behavior, impulsivity, and exploratory behavior has also recently been reviewed by <xref ref-type="bibr" rid="bibr29-1754073911421374">Carver (2005)</xref>, who put this into the context of other theories (e.g., <xref ref-type="bibr" rid="bibr155-1754073911421374">Strack &amp; Deutsch, 2004</xref>). His ideas draw heavily from the concept of <xref ref-type="bibr" rid="bibr64-1754073911421374">Gray and McNaughton (2000)</xref> relating approach tendency and impulsive action: They suggest that (a) the weaker the approach tendency, the lower is the likelihood of impulsive action, and (b) the stronger the approach tendency, the greater is the probability of impulsive action. In the presence of threat or novel cues, however, the behavioral inhibition system becomes active, generating anxiety and behavioral inhibition of ongoing approach. In terms of individual differences, a reactive behavioral inhibition system presumably permits little impulsive behavior. In contrast, low sensitivity of behavioral inhibition allows approach to be expressed more frequently.</p>
<p>According to <xref ref-type="bibr" rid="bibr29-1754073911421374">Carver (2005)</xref>, discussions of impulsive action typically focus on impulsiveness being relevant only to approach. However, impulsivity could also be viewed as equally important to aversion. Humans and animals alike probably vary in how impulsively, versus deliberatively, they act to avoid or withdraw from threats. <xref ref-type="bibr" rid="bibr29-1754073911421374">Carver (2005)</xref> suggests examining these possibilities; research investigating reactive control and effortful control must examine contexts in which the focus is on avoidance of threats, not just approach of incentives.</p>
<p>There is evidence that impulsive behavior is indicated by high open arm time percentage and high open arm entries in relation to total arm time and arm entries (<xref ref-type="bibr" rid="bibr162-1754073911421374">Ueno et al., 2002</xref>). Moreover, prenatal protein malnutrition increased rats’ exploratory behavior of the open arms of rats from both sexes in the elevated plus-maze (<xref ref-type="bibr" rid="bibr2-1754073911421374">Almeida, Garcia, &amp; de Oliveira, 1993</xref>; <xref ref-type="bibr" rid="bibr3-1754073911421374">Almeida, Tonkiss, &amp; Galler, 1996</xref>). These results could also be interpreted as higher impulsiveness; that is, prenatal malnutrition could lead to deficits in behavioral inhibition, resulting in increased exploration of open arms in the elevated plus-maze (<xref ref-type="bibr" rid="bibr2-1754073911421374">Almeida et al., 1993</xref>, <xref ref-type="bibr" rid="bibr3-1754073911421374">1996</xref>). Supporting this view, perinatally malnutritioned rats exhibit more errors at adult age in a procedure of differential reinforcement of low response rates. This suggests that the rats have problems inhibiting operant responses for food/water reward (<xref ref-type="bibr" rid="bibr23-1754073911421374">Brioni &amp; Orsingher, 1988</xref>).</p>
<p>However, there is also evidence contrary to the idea that increased impulsivity is related to higher approach behavior, that is, to spending more time in the open arms. Contrary to the assumption that impulsivity is dominant in the expression of elevated plus-maze behavior, <xref ref-type="bibr" rid="bibr11-1754073911421374">Binder, Droste, Ohl, and Reul (2004)</xref> observed after 4 weeks of voluntary exercise that mice appear to exhibit decreased anxiety-like/avoidance behavior in the elevated plus-maze (i.e., more open arm time), but also decreased impulsiveness (e.g., a longer latency to enter the centre of an open field) in various behavioral tests. These results are in contrast to the view that increased impulsivity is associated with reduced anxiety in the elevated plus-maze (i.e., more open arm time). Further evidence for a dissociation of anxiety and impulsivity in rodents stems from a series of studies by Petitto and colleagues (<xref ref-type="bibr" rid="bibr122-1754073911421374">Petitto, Lysle, Gariepy, &amp; Lewis, 1994</xref>; <xref ref-type="bibr" rid="bibr123-1754073911421374">Petitto et al., 1993</xref>). They found that selectively bred low-aggressive mice as opposed to selectively bred high-aggressive mice did not result in differences in the elevated plus-maze. Interestingly, the authors characterized the low-aggressive mice as “socially inhibited” (<xref ref-type="bibr" rid="bibr122-1754073911421374">Petitto et al., 1994</xref>; <xref ref-type="bibr" rid="bibr123-1754073911421374">Petitto et al., 1993</xref>), therefore suggesting no relationship between impulsivity and anxiety-like behaviors.</p>
<p>To summarize, it is important to elucidate the potential role of impulsivity, and to disentangle possible relationships with the different types of anxiety and fear with respect to elevated plus-maze behavior. Until the concept of impulsivity becomes better understood, one cannot fully rule out that impulsive behaviorc may also play a role in the elevated plus-maze. However, there is little, and even controversial, data on impulsivity in the elevated plus-maze, but there is substantial evidence for anxiety-related behavior in this test.</p>
</sec>
<sec id="section5-1754073911421374">
<title>Anxiety and Fear as Two Distinct Behavioral Systems</title>
<p>Personality researchers nowadays have acknowledged that anxiety and fear are two distinct behavioral systems (<xref ref-type="bibr" rid="bibr37-1754073911421374">Depue &amp; Lenzenweger, 2005</xref>; <xref ref-type="bibr" rid="bibr64-1754073911421374">Gray &amp; McNaughton, 2000</xref>; <xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton &amp; Corr, 2004</xref>). The theoretical categorical distinction between fear and anxiety derives from detailed analyses of defensive responses and their regulation in animals, explaining the pattern of associations between emotion and defensive behavior in terms of the differing functional demands arising from cautious approach to threat (anxiety) versus departure from threat (fear) (e.g., <xref ref-type="bibr" rid="bibr12-1754073911421374">Blanchard &amp; Blanchard, 1988</xref>; <xref ref-type="bibr" rid="bibr61-1754073911421374">Graeff, 1994</xref>). Evidence for this differentiation also stems from a translational model of fear and anxiety in humans (<xref ref-type="bibr" rid="bibr121-1754073911421374">Perkins et al., 2009</xref>).</p>
<p>For example, the studies of <xref ref-type="bibr" rid="bibr37-1754073911421374">Depue and Lenzenweger (2005)</xref> argue for the independence of anxiety and fear within the literature on personality traits, showing that the relationship between neuroticism (anxiety) and harm avoidance (fear) is approaching zero. Additionally, one of the most reliable indices of conditioned fear in animals is behavioral inhibition (<xref ref-type="bibr" rid="bibr35-1754073911421374">Davis, Walker, &amp; Lee, 1997</xref>; <xref ref-type="bibr" rid="bibr111-1754073911421374">Panksepp, 1998</xref>; <xref ref-type="bibr" rid="bibr124-1754073911421374">Phelps &amp; LeDoux, 2005</xref>), which is not the case for stimulus-induced anxiety-like behavior (<xref ref-type="bibr" rid="bibr35-1754073911421374">Davis et al., 1997</xref>). In parallel, other personality psychologists (<xref ref-type="bibr" rid="bibr157-1754073911421374">Tellegen &amp; Waller, 1992</xref>), behavioral neuroscientists (e.g., <xref ref-type="bibr" rid="bibr6-1754073911421374">Andreatini et al., 2001</xref>; <xref ref-type="bibr" rid="bibr36-1754073911421374">Deakin &amp; Graeff, 1991</xref>; <xref ref-type="bibr" rid="bibr62-1754073911421374">Graeff, Guimarães, De Andrade, &amp; Deakin, 1996</xref>), and clinical psychologists (e.g., <xref ref-type="bibr" rid="bibr9-1754073911421374">Barlow, 2002</xref>; <xref ref-type="bibr" rid="bibr179-1754073911421374">Yehuda &amp; Hyman, 2005</xref>; but see <xref ref-type="bibr" rid="bibr98-1754073911421374">Marks &amp; Nesse, 1994</xref>, for a different view) also postulate that anxiety and fear are different emotions.</p>
<p>A clear distinction between fear and anxiety has been postulated by <xref ref-type="bibr" rid="bibr64-1754073911421374">Gray and McNaughton (2000)</xref> and <xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton and Corr (2004)</xref>, which had not been evident in the initial theory (<xref ref-type="bibr" rid="bibr63-1754073911421374">Gray, 1982</xref>). The authors postulate that “fear has the function of moving the animal <italic>away</italic> from danger” (<xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton &amp; Corr, 2004</xref>, p. 286, emphasis added), resembling the defensive avoidance system, whereas “in an approach–avoidance conflict situation, anxiety has the function of moving the animal <italic>toward</italic> danger” (<xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton &amp; Corr, 2004</xref>, p. 286), resembling the defensive approach system, suggesting that the defensive direction is the critical factor. Conversely, <xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton and Corr (2004)</xref> critically comment that the differentiation between fear and anxiety is not dependent on the conditioned or unconditioned nature of the stimuli (see the literature for the defensive burying test first reported by <xref ref-type="bibr" rid="bibr126-1754073911421374">Pinel &amp; Treit, 1978</xref>). The fear system is insensitive to anxiolytic drugs, while anxiety involves inhibitory behavior and enhanced risk assessment. Accordingly, the core features of anxiety are sensitive to anxiolytic drugs, which also enhance exploration behavior and novelty seeking.</p>
<p>For example, approach to threat corresponding to anxiety (e.g., open arm approach) and avoidance of threat corresponding to fear (e.g., open arm avoidance) can be typically observed in an elevated plus-maze. This view is similar to that of <xref ref-type="bibr" rid="bibr37-1754073911421374">Depue and Lenzenweger (2005)</xref>, who claim that behavioral inhibition will not allow the individual to explore the environment to discover if the situation is threatening. Thus, increased attentional scanning of the uncertain surroundings, and cognitive worrying about possible outcomes, may resolve the uncertainty when a rat enters an open arm: Caution, slow approach, heightened attentional scanning, and enhanced cognitive activity are optimal, whereas freezing is not. In contrast, in the case of fear-conditioned stimuli the motor response is not escape, but rather freezing or behavioral inhibition (<xref ref-type="bibr" rid="bibr89-1754073911421374">LeDoux, 2000</xref>; <xref ref-type="bibr" rid="bibr124-1754073911421374">Phelps &amp; LeDoux, 2005</xref>).</p>
</sec>
</sec>
<sec id="section6-1754073911421374">
<title>The “One-Trial Tolerance Effect”</title>
<p>One as yet unresolved feature of testing with the elevated plus-maze is the “one-trial tolerance effect.” This phenomenon refers to the partial, or even total, disappearance of the anxiolytic-like effects of benzodiazepines if an animal is tested twice in the elevated plus-maze (<xref ref-type="bibr" rid="bibr44-1754073911421374">File, 1990</xref>). There is a marked neurochemical distinction between Trial 1 and Trial 2 (intertest interval ranging between 24 hours to 2 weeks). Benzodiazepines exert pronounced anxiolytic-like/approach effects to the elevated plus-maze when administered before a first exposure (Trial 1) of undrugged rats and mice. However, it has been shown that mice and rats with previous experience of the elevated plus-maze show a reduced, or even absent, anxiolytic-like/approach response to benzodiazepines (<xref ref-type="bibr" rid="bibr44-1754073911421374">File, 1990</xref>; <xref ref-type="bibr" rid="bibr49-1754073911421374">File, Mabbutt, &amp; Hitchcott, 1990</xref>; <xref ref-type="bibr" rid="bibr51-1754073911421374">File, Zangrossi, Viana, &amp; Graeff, 1993</xref>; <xref ref-type="bibr" rid="bibr58-1754073911421374">Gonzalez &amp; File, 1997</xref>; <xref ref-type="bibr" rid="bibr92-1754073911421374">Lister, 1987</xref>; <xref ref-type="bibr" rid="bibr120-1754073911421374">Pereira, Vieira, Konishi, Ribeiro, &amp; Frussa-Filho, 1999</xref>; <xref ref-type="bibr" rid="bibr135-1754073911421374">Rodgers, Lee, &amp; Shepherd, 1992</xref>; <xref ref-type="bibr" rid="bibr136-1754073911421374">Rodgers &amp; Shepherd, 1993</xref>). This tolerance appears to be general to tests other than the elevated plus-maze like the light–dark box, which typically tests the nonforced transition behavior from a dark, narrow, and closed box to a bright and open space (<xref ref-type="bibr" rid="bibr136-1754073911421374">Rodgers &amp; Shepherd, 1993</xref>). In contrast, responses to serotonergic manipulation become also prominent in Trial 2 (<xref ref-type="bibr" rid="bibr46-1754073911421374">File, Andrews, Wu, Zharkovsky, &amp; Zangrossi, 1992</xref>).</p>
<p><xref ref-type="bibr" rid="bibr51-1754073911421374">File et al. (1993)</xref> found that the measures of anxiety-like/avoidance behavior derived from Trials 1 and 2 in the elevated plus-maze load on two independent factors, that is, two distinct states of anxiety-like/avoidance behaviors are generated in the two trials and this has been confirmed in mice (<xref ref-type="bibr" rid="bibr77-1754073911421374">Holmes &amp; Rodgers, 1998</xref>). The lack of anxiolytic-like effects of benzodiazepines in Trial 2 is suggested to reflect the inefficacy in fear which predominates behavior in Trial 2 (<xref ref-type="bibr" rid="bibr33-1754073911421374">Cruz-Morales, Santos, &amp; Brandão, 2002</xref>). In trying to understand the effects it seems that the open aspect of the arms is important in controlling behavior in Trial 1 (<xref ref-type="bibr" rid="bibr161-1754073911421374">Treit, Menard, &amp; Royan, 1993</xref>), whereas it may be the elevation that is most critical in Trial 2 (<xref ref-type="bibr" rid="bibr41-1754073911421374">Fernandes &amp; File, 1996</xref>).</p>
<p>The loss of the anxiolytic-like action of benzodiazepines in Trial 2 occurs only when the trials last the typical 5 minutes. When the trials are longer (i.e., 10 minutes on each trial), however, benzodiazepines retain anxiolytic-like/approach efficacy (<xref ref-type="bibr" rid="bibr51-1754073911421374">File et al., 1993</xref>). The question remains then why benzodiazepines retained anxiolytic-like/approach efficacy when prolonged exposure to the aversive phobic should have already increased anxiolytic-like/approach behavior to the open arms? This raises the possibility that the second form of avoidance behavior (i.e., phobia) may be rapidly extinguished with further exposure to the elevated plus-maze. This rapid extinction is consistent with the possibility that Trial 2 behavior in the elevated plus-maze represents a fear-like state to heights, since phobias do diminish as a result of exposure to the phobic situation (<xref ref-type="bibr" rid="bibr97-1754073911421374">Marks, 1987</xref>). In addition, it is also known that benzodiazepines are not helpful when treating specific phobias in patients. Therefore, a prolonged exposure to the elevated plus-maze may finally end the specific phobia, but again exhibits differences in anxiolytic-like/approach behavior as during the first plus-maze test. In addition, <xref ref-type="bibr" rid="bibr55-1754073911421374">Frussa-Filho and Ribeiro (2002)</xref> showed that previous exposure to a four-enclosed-arm elevated plus-maze induced the phenomenon of one-trial tolerance, whereas previous exposure to a four-open-arm apparatus did not. Therefore the authors hypothesize that the phenomenon of one-trial tolerance is not due to the acquisition of a phobic avoidance of open arms, but to the discovery and exploration of relatively safe places such as the closed arms (<xref ref-type="bibr" rid="bibr55-1754073911421374">Frussa-Filho &amp; Ribeiro, 2002</xref>). Other hypotheses regarding the resistance of anxiolytic behaviour to pharmacological substances with repeated elevated plus-maze tests are summarized in <xref ref-type="bibr" rid="bibr28-1754073911421374">Carobrez and Bertoglio (2005)</xref>. For example, the one-trial tolerance phenomenon can be prevented when changing the context between trials: Rodents continue to display an anxiolytic-like profile in response to drugs in the elevated plus-maze Trial 2 when a new motivational conflict situation (e.g., light and hot air blow; <xref ref-type="bibr" rid="bibr120-1754073911421374">Pereira et al., 1999</xref>, food and water deprivation for 24 hours, or introduction of a novel object in the open arm; <xref ref-type="bibr" rid="bibr7-1754073911421374">Andreatini, Vital, &amp; Santos, 2003</xref>) is introduced in the test. Our group is currently systematically testing an extension of such preliminary evidence by neither depriving the animals nor manipulating the plus-maze apparatus as such to avoid the one-trial tolerance effect (<xref ref-type="bibr" rid="bibr143-1754073911421374">Schneider, Ho, Spanagel, &amp; Pawlak, 2011</xref>).</p>
<sec id="section7-1754073911421374">
<title>Psychopharmacology and Neuroanatomy</title>
<p>A bewildering array of neurotransmitters, peptides, hormones, and other chemical messengers have been discussed and suggested as potential modulators of anxiety in humans and animals (see review by <xref ref-type="bibr" rid="bibr103-1754073911421374">Millan, 2003</xref>). It is beyond the scope of the present work to report evidence for all of these substances. Antidepressants, neuroleptics, and stimulants show different and incoherent effects (reviews by <xref ref-type="bibr" rid="bibr119-1754073911421374">Pellow et al., 1985</xref>; <xref ref-type="bibr" rid="bibr133-1754073911421374">Rodgers et al., 1997</xref>). Until now, sensitivity to anxiolytic-like effects in the elevated plus-maze appears to be limited to benzodiazepine/GABA-related compounds (review by <xref ref-type="bibr" rid="bibr18-1754073911421374">Borsini, Podhorna, &amp; Marazziti, 2002</xref>), although far less work has been done on chronic administration of antidepressants in anxiety models as such, including the elevated plus-maze. According to <xref ref-type="bibr" rid="bibr18-1754073911421374">Borsini et al. (2002)</xref>, acute or chronic administration with antidepressants acting on noradrenergic and dopaminergic mechanisms showed no effects.</p>
<p>There is an increasing number of studies dealing with the neuroanatomy of elevated plus-maze behavior and relevant neuroanatomical areas and tissues. The structures considered to be most relevant are the raphe nuclei (e.g., <xref ref-type="bibr" rid="bibr26-1754073911421374">Canto-de-Souza, Nunes-de-Souza, &amp; Rodgers, 2002</xref>), hippocampus (e.g., <xref ref-type="bibr" rid="bibr109-1754073911421374">Nunes-de-Souza, Canto-de-Souza, &amp; Rodgers, 2002</xref>), and amygdala (e.g., <xref ref-type="bibr" rid="bibr47-1754073911421374">File, Gonzalez, &amp; Gallant, 1998</xref>). However, recent work suggests the involvement of tissues other than the limbic system for anxiety-like/avoidance behavior in the elevated plus-maze, such as the striatum (e.g., <xref ref-type="bibr" rid="bibr113-1754073911421374">Pawlak, Ho, Schwarting, &amp; Bauhofer, 2003</xref>; <xref ref-type="bibr" rid="bibr115-1754073911421374">Pawlak &amp; Schwarting, 2006a</xref>; <xref ref-type="bibr" rid="bibr149-1754073911421374">Schwarting, Thiel, Müller, &amp; Huston, 1998</xref>; see discussion in following paragraphs), the bed nucleus of the stria terminalis (e.g., <xref ref-type="bibr" rid="bibr171-1754073911421374">Wigger et al., 2004</xref>), septum (e.g., <xref ref-type="bibr" rid="bibr91-1754073911421374">Liebsch, Wotjak, Landgraf, &amp; Engelmann, 1996</xref>), as well as the (medial) prefrontal cortex (e.g., <xref ref-type="bibr" rid="bibr117-1754073911421374">Pawlak, Schwarting, &amp; Bauhofer, 2005</xref>; <xref ref-type="bibr" rid="bibr147-1754073911421374">Schwabe, Klein, &amp; Koch, 2006</xref>).</p>
</sec>
<sec id="section8-1754073911421374">
<title>Validity</title>
<p>The translational value of animal research is an often neglected area in basic and preclinical research. Thus, it is of crucial importance to determine criteria for animal research that are comparable with human conditions. For example, in all animal models for psychiatric conditions three types of validity have been suggested, namely, predictive, face, and construct validity (e.g., <xref ref-type="bibr" rid="bibr118-1754073911421374">Pawlak &amp; Weyers, 2006</xref>; <xref ref-type="bibr" rid="bibr132-1754073911421374">Rodgers, 1997</xref>; <xref ref-type="bibr" rid="bibr160-1754073911421374">Treit, 1985</xref>; <xref ref-type="bibr" rid="bibr173-1754073911421374">Willner, 1986</xref>; <xref ref-type="bibr" rid="bibr175-1754073911421374">Willner &amp; Mitchell, 2002</xref>). This framework will be briefly introduced.</p>
<p><italic>Predictive validity</italic> denotes the evaluation of drug effects in animal models resembling effects in the clinic, or as <xref ref-type="bibr" rid="bibr172-1754073911421374">Willner (1984)</xref> puts it, the performance in a given test predicts the performance in the modelled condition. The predictive validity of the elevated plus-maze is good with regard to the effectiveness of benzodiazepine/GABAergic drugs, but inconsistent evidence has been shown for various neuropeptides and serotonergic drugs. However, recently there have been a number of promising studies with chronic treatment, showing that not only GABA but also 5-HT can alter behavior which resembles treatment modulated behavior of anxiety disorders (<xref ref-type="bibr" rid="bibr40-1754073911421374">Fedotova, Hartmann, Lénárd, &amp; Sapronov, 2004</xref>; <xref ref-type="bibr" rid="bibr107-1754073911421374">Motta, Maisonnette, Morato, Castrechini, &amp; Brandão, 1992</xref>; <xref ref-type="bibr" rid="bibr150-1754073911421374">Silva &amp; Brandão, 2000</xref>). Aforementioned, central neuroanatomical areas of the limbic system are involved in both animals and humans.</p>
<p><italic>Face validity</italic> denotes the phenomenological similarity between the animal model and its disorder (<xref ref-type="bibr" rid="bibr1-1754073911421374">Abramson &amp; Seligman, 1977</xref>; <xref ref-type="bibr" rid="bibr100-1754073911421374">McKinney &amp; Bunney, 1969</xref>; <xref ref-type="bibr" rid="bibr172-1754073911421374">Willner, 1984</xref>), or at a minimum draws comparisons of such behavior to nonpathological conditions of anxiety-like/avoidance behavior.</p>
<p><italic>Construct validity</italic> denotes the evaluation of the theoretical rationale of an animal model (<xref ref-type="bibr" rid="bibr172-1754073911421374">Willner, 1984</xref>). For example, <xref ref-type="bibr" rid="bibr173-1754073911421374">Willner (1986)</xref> argues that human behavior and animal behavior should be based on comparable psychological and neurobiological mechanisms. Construct validity should also take into account principles of the aetiology of a disorder. There are still a number of unresolved questions relating to construct validity of the elevated plus-maze as a model for anxiety and phobia disorders. For example, it is not clear to what extent the elevated plus-maze can be used to gauge behavior to model specific human disorders. There are suggestions that the first trial with naive animals is a model for generalized anxiety or panic, whereas the second test 24 hours later could be a model for specific phobias (e.g., <xref ref-type="bibr" rid="bibr41-1754073911421374">Fernandes &amp; File, 1996</xref>; <xref ref-type="bibr" rid="bibr48-1754073911421374">File, Kenny, &amp; Cheeta, 2000</xref>; <xref ref-type="bibr" rid="bibr50-1754073911421374">File &amp; Zangrossi, 1993</xref>). With respect to statements regarding the specificity of the elevated plus-maze, <xref ref-type="bibr" rid="bibr18-1754073911421374">Borsini et al. (2002)</xref> postulated inevitable experiments with chronic drug treatments that mimic the clinical aspects more closely (this need is also evident for basically all other animal models of anxiety). Recently, there have been approaches increasing in numbers showing promising results. For example, the 5-HT<sub>1A</sub> receptor agonist gepirone showed acute anxiogenic but chronic anxiolytic effects (<xref ref-type="bibr" rid="bibr150-1754073911421374">Silva &amp; Brandão, 2000</xref>).</p>
<p>It needs to be noted that the present review is not intended to be exhaustive and there are possibly more anxiety/ avoidance tests that resemble the elevated plus-maze paradigm. Nonetheless, the validation of these recent alternative developments is still fragmentary and needs more research. Thus, the elevated plus-maze remains the most applied test for unconditioned avoidance behavior. It is likely to remain the main paradigm, at least in the near future.</p>
</sec>
</sec>
<sec id="section9-1754073911421374">
<title>Individuality in Animal Models</title>
<p>Typically, researchers of animal behavior attempt to avoid variance in their outcomes. Deviations from homogeneous results, or even outliers, are to be avoided, omitted, or at best tolerated in the final reports. However, for a number of decades it has been the aim of several research groups to take advantage of large variances in animal research and to scrutinize such variability systematically. To do so, it is important to establish methodologies to assess behavioral traits in animals and to differentiate between conspecifics of a given species. “Trait” is defined here as a pattern of a specific behavior, which differs between individuals, but which is relatively constant within subjects over time and situations (<xref ref-type="bibr" rid="bibr4-1754073911421374">Amelang, Bartussek, Stemmler, &amp; Hagemann, 2006</xref>). This term is usually used in animal behavioral research instead of “personality” in humans.</p>
<p>There is a wide range of animal behaviors suggested to reflect personality dimensions in humans such as, for example, avoidance behavior in chimpanzees (<xref ref-type="bibr" rid="bibr180-1754073911421374">Yerkes &amp; Yerkes, 1936</xref>), neuroticism in horses (<xref ref-type="bibr" rid="bibr106-1754073911421374">Morris, Gale, &amp; Duffy, 2002</xref>), nervousness in response to other animals in chickens (<xref ref-type="bibr" rid="bibr70-1754073911421374">Hasuo, 1935</xref>), response to females in newts (<xref ref-type="bibr" rid="bibr67-1754073911421374">Halliday, 1976</xref>), exposure to a mirror and aggression in the Midas cichlid (<xref ref-type="bibr" rid="bibr54-1754073911421374">Francis, 1990</xref>), assertiveness in the spotted hyena (<xref ref-type="bibr" rid="bibr59-1754073911421374">Gosling, 1998</xref>), dominance behavior in baboons (<xref ref-type="bibr" rid="bibr139-1754073911421374">Sapolsky &amp; Ray, 1989</xref>), or social ability in Rhesus monkeys (<xref ref-type="bibr" rid="bibr27-1754073911421374">Capitanio, 1985</xref>), among others. Probably the most studied dimensions of individual differences of behavior in animals, however, relate to anxiety, activity, and exploratory behavior (excellently reviewed by <xref ref-type="bibr" rid="bibr60-1754073911421374">Gosling, 2001</xref>).</p>
<sec id="section10-1754073911421374">
<title>Approaches to Assess Systematic Variability in Animals</title>
<p>Mice and rats are the major experimental animals in the field of behavioral neuroscience, and various approaches have been pursued to analyze dimensions of anxiety and exploratory behavior. They extend from systematic behavioral differences in normal animals (i.e., not specifically bred for trait behavior) to the recently established genetic models. There are at least four methodological approaches when analyzing individual behavior of a cohort. First, a simple and effective approach is to correlate values of individuals on two dimensions which provide information about the extent of a relationship between individuals (e.g., avoidance behavior and corticosterone in the blood). For example, primarily cortisol is produced by humans, while in rodents mainly corticosterone is secreted from adrenal glands. Second, a cohort of animals is exposed to a behavioral test. The individuals are then divided into at least two subgroups according to their behavior (e.g., high and low open arm time), that is, using a median split, or extreme groups of a given population (e.g., upper and lower quartiles). Subsequently, additional assays of various types are performed. Third, selective breeding for behavioral dispositions has been carried out scientifically since the first half of the 20th century. There, the most common behavioral dimensions were lines bred for learning and memory experiments, psychomotor activation, addiction models, and emotionality. The fourth approach consists of the comparison of different strains (genetic variation minimized by inbreeding) of mice or rats, as well as inbred strains versus outbred stocks (genetically heterogeneous by crossing two or more strains), and finally of genetically manipulated animals.</p>
<p>The advantages of an individual-oriented approach of animal behavior are various. First, variance between individuals can be systematically reduced or at least explained. Second, systematic relationships between different behaviors or between behavior and biological functions can be measured more closely. Third, behavioral screening can be used for the prediction of pharmacological or behavioral reactivity in other tests. Fourth, differential animal behavior, with state or trait characteristics, can also be applied to analyze the susceptibility to disease models. Fifth, the approach makes it feasible to determine an array of behaviors in a broad range of species that resemble human personality dimensions; this then allows one to draw comparisons between animals and humans (<xref ref-type="bibr" rid="bibr60-1754073911421374">Gosling, 2001</xref>). The various reasons for the expression of individual differences, even in genetically identical animals, are summarized elsewhere in an overview by <xref ref-type="bibr" rid="bibr88-1754073911421374">Lathe (2004)</xref>, but are not the focus of the present studies.</p>
<p>It is commonly accepted that animal models make use of “selective” breeding for a specific trait. However, there has been no uniform term coined denoting animals stemming from a given sample population. Some authors have used the term “normal” as a means to filter outliers from sample populations based on the presence of strongly deviant behavior (<xref ref-type="bibr" rid="bibr82-1754073911421374">Karl, Pabst, &amp; von Hörsten, 2003</xref>). But this term may not fully account for the rat models introduced here, although it is also often used to denote animals that are naive to behavioral tests and pharmacological manipulations. Other terms such as “intact” or “healthy” are also in use. However, they are more restricted and lay the focus more on health-related issues. One needs to be cautious as such terms require (a) definitions of the terms “healthy” and “intact,” respectively, and (b) subsequent extensive health monitoring, which not all laboratories are capable of. For the rats used here, it would not be possible to know if they were all “healthy” or “intact” until the end of the experiments, although, for example, the weight of the rats provides a crude evaluation of the health status. The term “unselected” may also appear somewhat misleading since the rats used in given approaches have usually been selected for sex, age, stock, and breeding potential. Nonetheless, the term “unselected” appears to be the most appropriate expression since it basically comprises all individuals from a sample population, without making assumptions about their health status (“healthy,” “intact”), or claiming that they are “normal.”</p>
<p>In the following section the most comprehensive systematic approach of unconditioned anxiety-like/avoidance behavior based on unselected rodents tested in an elevated plus-maze will be introduced. Even more, to the best of our knowledge, this is the first systematic differential approach with unselected animals (i.e., not specifically bred for trait behavior) on anxiety-related behavior.</p>
</sec>
</sec>
<sec id="section11-1754073911421374">
<title>Anxiety-Like/Avoidance Behavior in Unselected Animals: High (HOA) and Low Open Arm (LOA) Rats</title>
<p>One approach to systematically analyzing variance in an unselected cohort of male rats has been successfully employed for elevated plus-maze behavior in our laboratories (<xref ref-type="bibr" rid="bibr112-1754073911421374">Pawlak et al., 2008</xref>; <xref ref-type="bibr" rid="bibr118-1754073911421374">Pawlak &amp; Weyers, 2006</xref>; <xref ref-type="bibr" rid="bibr148-1754073911421374">Schwarting &amp; Pawlak, 2004</xref>). All animals used in the studies described below were unselected, young adult (approximately 8 to 9 weeks old at arrival in the laboratory), male, outbred, Wistar Unilever rats generated by Harlan Winkelmann, Germany. Before experimental manipulations, the animals were divided by a median split upon their first exposure to the apparatus into those that spend less time on the open arms (LOA, that is, they show <italic>more</italic> anxiety-like/avoidance behavior), and those that spend more time on the open arms (HOA, that is, they show <italic>less</italic> anxiety-like/avoidance behavior).</p>
<p>First of all, significant retest reliability for a period of 24 hours or 120 days provides evidence for a relative stability of this dimension (<xref ref-type="bibr" rid="bibr148-1754073911421374">Schwarting &amp; Pawlak, 2004</xref>; see <xref ref-type="fig" rid="fig1-1754073911421374">Figure 1</xref>). The HOA Wistar rats showed less avoidance behavior of aversive objects in the unconditioned object burying test (<xref ref-type="bibr" rid="bibr73-1754073911421374">Ho, Eichendorff, &amp; Schwarting, 2002</xref>; see <xref ref-type="fig" rid="fig2-1754073911421374">Figure 2</xref>) and faster active avoidance learning in a shuttle box (<xref ref-type="bibr" rid="bibr73-1754073911421374">Ho et al., 2002</xref>). In comparison to LOA rats, they also showed less freezing behavior in a standard fear-conditioning paradigm on the conditioning and test day, respectively (<xref ref-type="bibr" rid="bibr21-1754073911421374">Borta et al., 2006</xref>; see <xref ref-type="fig" rid="fig3-1754073911421374">Figure 3</xref>). These differences seem not to be due to pain reactivity (<xref ref-type="bibr" rid="bibr19-1754073911421374">Borta &amp; Schwarting, 2005a</xref>). Finally, LOA and HOA rats did not differ regarding immobility in the forced swim test, an animal model related to depression (<xref ref-type="bibr" rid="bibr73-1754073911421374">Ho et al., 2002</xref>).</p>
<fig id="fig1-1754073911421374" position="float">
<label>Figure 1.</label>
<caption>
<p>Time in the open arm of an elevated plus-maze (expressed in percentage of total test time; <italic>M</italic> + <italic>SEM</italic>) in rats which were tested either on Day 1 (first exposure) and retested on Days 2 and 12 (left side), or in rats which were retested 120 days after the first exposure. Correlation coefficients (Spearman) reflect comparisons between the given test day and the first exposure (d1). Based on the amount of open arm time during the first test (d1), the animals were assigned either to the subgroup with low open arm (LOA) or high open arm (HOA) time. Adapted from <xref ref-type="bibr" rid="bibr148-1754073911421374">Schwarting and Pawlak (2004)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig1.tif"/>
</fig>
<fig id="fig2-1754073911421374" position="float">
<label>Figure 2.</label>
<caption>
<p>Time course of cumulated percentage of rats showing unconditioned object-burying behavior (A) and the number (<italic>M</italic> +<italic>SEM</italic>) of marbles buried (B). Four marbles coated with Tabasco sauce were introduced into the rat‘s home cage at 10 h. Asterisk (*) indicates a difference (<italic>p</italic> &lt; .05) between low open arm (LOA) compared with high open arm (HOA) rats at that time point. Adapted from <xref ref-type="bibr" rid="bibr73-1754073911421374">Ho, Eichendorff, and Schwarting (2002)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig2.tif"/>
</fig>
<fig id="fig3-1754073911421374" position="float">
<label>Figure 3.</label>
<caption>
<p>Freezing behavior (in seconds) during fear conditioning (top) and during testing (bottom) expressed separately for the six tone(t)/shock(s) (A; t/s-1 to t/s-6), or tone intervals (B; Tone 1 to Tone 6), and the six interstimulus intervals (A, B; ISI-1 to ISI-6). Open circles: rats with low open arm (LOA) time (<italic>n</italic> = 10), full circles: rats with high open arm (HOA) time in an elevated plus-maze. Adapted from <xref ref-type="bibr" rid="bibr21-1754073911421374">Borta et al. (2006)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig3.tif"/>
</fig>
<p>These results suggest that the performance of active coping behavior might be different between LOA and HOA rats in escapable stress, but not of passive coping in inescapable stress (forced swim test). This indicates that the individual anxiety-like/avoidance level has certain correlations with the ability to cope with environmental challenges. Furthermore, there are indications for positive correlations between ultrasound vocalization of pups and their adult behavior in an elevated plus-maze: Pups which utter more ultrasounds during separation spent more time on the open arms as adults, that is, they showed less anxiety-like/avoidance behavior (<xref ref-type="bibr" rid="bibr148-1754073911421374">Schwarting &amp; Pawlak, 2004</xref>). When these subgroups were tested in a standard fear-conditioning paradigm, adult LOA rats now emitted more calls, and with higher peak frequency, than their HOA counterparts (<xref ref-type="bibr" rid="bibr21-1754073911421374">Borta et al., 2006</xref>). On the subsequent testing day, ultrasound call differences between groups were no longer detectable (<xref ref-type="bibr" rid="bibr21-1754073911421374">Borta et al., 2006</xref>).</p>
<p>Interestingly, behavior in all studies except one (<xref ref-type="bibr" rid="bibr19-1754073911421374">Borta &amp; Schwarting, 2005a</xref>) consistently showed no relationships between anxiety-related profiles in an elevated plus-maze and vertical psychomotor activation (rearings) in a novel open field, performed in different laboratories, with different experimenters, and with different animal providers (<xref ref-type="bibr" rid="bibr20-1754073911421374">Borta &amp; Schwarting, 2005b</xref>; <xref ref-type="bibr" rid="bibr73-1754073911421374">Ho et al., 2002</xref>; <xref ref-type="bibr" rid="bibr114-1754073911421374">Pawlak &amp; Schwarting, 2002</xref>; <xref ref-type="bibr" rid="bibr149-1754073911421374">Schwarting et al., 1998</xref>; <xref ref-type="bibr" rid="bibr158-1754073911421374">Thiel, Müller, Huston, &amp; Schwarting, 1999</xref>).</p>
<p>Concerning pharmacologcial reactivity, differences following a single systemic injection of the amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) 15 days after drug treatment became evident during active avoidance learning. There was a significant interaction between treatments and subgroups, since the number of avoidances in vehicle-treated LOA rats was lower than in vehicle-treated HOA rats. Furthermore, MDMA-treated HOA rats showed less avoidance behavior than vehicle-treated HOA rats (<xref ref-type="bibr" rid="bibr74-1754073911421374">Ho, Pawlak, Guo, &amp; Schwarting, 2004</xref>; see <xref ref-type="fig" rid="fig4-1754073911421374">Figure 4</xref>). A more recent study (<xref ref-type="bibr" rid="bibr95-1754073911421374">Ludwig, Mihov, &amp; Schwarting, 2008</xref>) showed that HOA and LOA rats also responded differently to a regimen of repeated MDMA treatments. Additionally, HOA rats showed higher phasic rectal body temperature following handling stress (<xref ref-type="bibr" rid="bibr74-1754073911421374">Ho et al., 2004</xref>).</p>
<fig id="fig4-1754073911421374" position="float">
<label>Figure 4.</label>
<caption>
<p>The number of avoidances (<italic>M</italic> + <italic>SEM</italic>) during three consecutive blocks of five trials each in an active avoidance learning test. Fifteen days before, the animals had received either an i.p. injection of vehicle (left) or 7.5 mg/kg MDMA. Asterisk (*) indicates a difference (<italic>p</italic> &lt; .05) between low (LOA; full circles) and high open arm (HOA; open circles) rats, and ## indicates a difference (<italic>p</italic> &lt; .01) between vehicle- and MDMA-treated HOA rats. Adapted from <xref ref-type="bibr" rid="bibr74-1754073911421374">Ho et al. (2004)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig4.tif"/>
</fig>
<p>Analyses of postmortem neurochemistry revealed relationships between open arm time in an elevated plus-maze and 5-HT in the brain. LOA animals had lower tissue levels of 5-HT in the ventral striatum but not in other brain areas (<xref ref-type="bibr" rid="bibr149-1754073911421374">Schwarting et al., 1998</xref>; see <xref ref-type="fig" rid="fig5-1754073911421374">Figure 5</xref>).</p>
<fig id="fig5-1754073911421374" position="float">
<label>Figure 5.</label>
<caption>
<p>Analyses of postmortem neurochemistry of 5-HT in the brain. For each group and brain area, two bars are given, which refer to data of the left and right brain hemisphere, respectively. Rats with low open arm (LOA) compared to high open arm (HOA) time had lower tissue levels of 5-HT in the ventral striatum but not in other brain areas (<italic>M</italic> + <italic>SEM</italic>). *<italic>p</italic> &lt; .05, represents significant difference between HOA and LOA rats (unpaired <italic>t</italic> tests). Adapted from <xref ref-type="bibr" rid="bibr149-1754073911421374">Schwarting et al. (1998)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig5.tif"/>
</fig>
<p>Furthermore, there were no differences between the two LOA and HOA groups of animals with respect to noradrenaline or dopamine levels (<xref ref-type="bibr" rid="bibr149-1754073911421374">Schwarting et al., 1998</xref>). Differences were obtained on neuroimmunological levels showing that LOA rats had higher striatal (i.e., striatum), and less prefrontal IL(interleukin)-2 mRNA (messenger ribonucleic acid)—but not IL-1β, IL-6, and TNF-α mRNA—compared to HOA rats (<xref ref-type="bibr" rid="bibr113-1754073911421374">Pawlak et al., 2003</xref>, <xref ref-type="bibr" rid="bibr117-1754073911421374">2005</xref>; see <xref ref-type="fig" rid="fig6-1754073911421374">Figure 6</xref>). These results indicate that the relationship between anxiety-like/avoidance behavior and central cytokines is site- (striatum, prefrontal cortex), and cytokine-specific (IL-2 mRNA). Subsequent striatal microinjection studies supported the otherwise correlative link between IL-2 and anxiety-related behavior (<xref ref-type="bibr" rid="bibr83-1754073911421374">Karrenbauer et al., 2009</xref>; <xref ref-type="bibr" rid="bibr115-1754073911421374">Pawlak &amp; Schwarting, 2006a</xref>, <xref ref-type="bibr" rid="bibr116-1754073911421374">2006b</xref>). In addition, anxiety-like/avoidance levels in half of a female rat sample were increased by ovariectomy. After chronic treatment with dioscorea, a Chinese medicine, a decrease in anxiety-like/avoidance behavior and IL-2 levels in the cerebral cortex was observed in the LOA ovariectomized rats, whereas administration of dioscorea increased anxiety-like/avoidance behavior and IL-2 levels in the prefrontal cortex in HOA ovariectomized rats (<xref ref-type="bibr" rid="bibr75-1754073911421374">Ho et al., 2007</xref>).</p>
<fig id="fig6-1754073911421374" position="float">
<label>Figure 6.</label>
<caption>
<p>Cytokine expression levels in different central and peripheral tissues of animals with high open arm (HOA) or low open arm (LOA) behavior. Based on the percentage of open arm time, LOA compared to HOA rats expressed higher levels of IL-2 mRNA in the striatum, and lower IL-2 mRNA expression in the prefrontal cortex. Other cytokines did not differ between the two subgroups. *<italic>p</italic> &lt; .05 represents significant difference between HOA and LOA rats. Data are expressed as <italic>M</italic> + <italic>SEM</italic>. Adapted from <xref ref-type="bibr" rid="bibr113-1754073911421374">Pawlak et al. (2003</xref>, <xref ref-type="bibr" rid="bibr117-1754073911421374">2005</xref>).</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig6.tif"/>
</fig>
<p>Our laboratory recently analyzed dyadic social interaction behavior of HOA and LOA rats. During the test of two rats an increase in social interaction is interpreted as anxiolytic-like behavior. Our results showed that the most frequent behavior, that is, nonanogenital sniffing, was substantially higher for HOA/HOA dyads on the first testing day (<xref ref-type="bibr" rid="bibr145-1754073911421374">Schneider, Spanagel, Schwarting, &amp; Pawlak, 2008</xref>). Then, we tested the effects of a single systemic IL-2 injection on differential social interaction behavior in relation to HOA and LOA traits. The results showed treatment effects of IL-2 treated LOA rats on social interaction behavior compared to vehicle injected LOA animals. Additionally, we found a tendency of IL-2 treated HOA rats to show overall more social interaction than LOA animals (<xref ref-type="bibr" rid="bibr144-1754073911421374">Schneider, Spanagel, &amp; Pawlak, 2009</xref>).</p>
<p>D-cycloserine, a partial agonist of glycine binding site on <italic>N</italic>-methyl-D-aspartate (NMDA) glutamate receptors, was found to suppress the immobility in the Day 2 trial of the forced swim test in LOA rats (<xref ref-type="bibr" rid="bibr178-1754073911421374">Wu et al., 2008</xref>; see <xref ref-type="fig" rid="fig7-1754073911421374">Figure 7</xref>). In parallel, postmortem analyses showed that LOA but not HOA rats had increased levels of phosphorylation of extracellular signal-regulated kinase1/2 (p-ERK1/2) in the amygdala following D-cycloserine treatment (<xref ref-type="bibr" rid="bibr178-1754073911421374">Wu et al., 2008</xref>; see <xref ref-type="fig" rid="fig7-1754073911421374">Figure 7</xref>). These findings indicate different sensitivities of p-ERK1/2, IL-2, and behavioral responses to the treatment of D-cycloserine between HOA and LOA rats, suggesting that the activity of NMDA receptor-mediated ERK1/2 signaling and cytokine (IL-2) function in the brain are related to individual behavioral differences of anxiety.</p>
<fig id="fig7-1754073911421374" position="float">
<label>Figure 7.</label>
<caption>
<p>Role of anxiety level in the effects of D-cycloserine (DCS) on the immobility of rats in forced swim test and the activation of ERK1/2 (p-ERK1/2) in the amygdala. Thirty minutes after the treatment of DCS (30 mg/kg, i.p.), the immobility in the Day 2 trial of the forced swim test is suppressed (A), but the p-ERK1/2 level in the amygdala is increased in LOA (low open arm) but not HOA (high open arm) rats (B). Data are expressed as <italic>M</italic> + <italic>SEM</italic>. **<italic>p</italic> &lt; .01, ***<italic>p</italic> &lt; .001, compared to the Day 1 session. <sup>###</sup><italic>p</italic> &lt; .001, compared to the rats treated by vehicle in the LOA subgroup. Adapted from <xref ref-type="bibr" rid="bibr178-1754073911421374">Wu et al. (2008)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1754073911421374-fig7.tif"/>
</fig>
<p>Taken together, the HOA and LOA Wistar rats can be distinguished in a number of behavioral paradigms, psychopharmacological reactivity, neurochemistry, and physiology. Our approach takes advantage of the fact that there are existing systematic stable natural variances that may resemble conditions of a wide spectrum of behaviors and their related physiology. We suggest this approach to be particularly suitable to display a continuum of a population, including extremes on both ends, rather than following a rigid selective dichotomy, because our results often also showed substantial individual correlations between parameters when analyzing all animals of a given sample.</p>
</sec>
<sec id="section12-1754073911421374">
<title>How Does Our Approach Interface with Theories of Anxiety?</title>
<p>The basal ganglia system contains several nuclei, and some of them are often labeled inconsistently, which is partly due to the type of species under study. One part of this brain system is the striatum, which consists of a dorsal (upper) and a ventral (lower) part. Here, the term striatum will be used.</p>
<p>The potential role for cytokines, especially IL-2, was discussed before. But what is still not clear is how these actions of IL-2 in the striatum and behavior fit into existing theories of aversive emotions. The theory of anxiety by <xref ref-type="bibr" rid="bibr64-1754073911421374">Gray and McNaughton (2000)</xref> and <xref ref-type="bibr" rid="bibr101-1754073911421374">McNaughton and Corr (2004)</xref> postulates behavioral (i.e., fear and anxiety) and neurobiological distinctions between panic (periaqueductal grey), phobia (hypothalamus/amygdala), and anxiety (amygdala/ septo-hippocampal system). According to them, neural control of fear relative to anxiety is more elaborated at lower levels of the neural system, whereas anxiety is considered to be relatively more elaborated at higher brain levels (see previous lines). The anxiety-like/avoidance effects of IL-2 in the striatum (<xref ref-type="bibr" rid="bibr83-1754073911421374">Karrenbauer et al., 2009</xref>; <xref ref-type="bibr" rid="bibr115-1754073911421374">Pawlak &amp; Schwarting, 2006a</xref>), and the frontal-striatal relationships between these neuroanatomical areas and IL-2 and anxiety-like/avoidance behavior (<xref ref-type="bibr" rid="bibr113-1754073911421374">Pawlak et al., 2003</xref>, <xref ref-type="bibr" rid="bibr117-1754073911421374">2005</xref>), appear to fit since the prefrontal cortex also plays a critical role in complex anxiety such as social anxiety (<xref ref-type="bibr" rid="bibr64-1754073911421374">Gray &amp; McNaughton, 2000</xref>). However, in the theory by <xref ref-type="bibr" rid="bibr64-1754073911421374">Gray and McNaughton (2000)</xref> the striatum is not critically involved in anxiety-like/avoidance behavior. This points to a role for the striatum in this emotional behavior that is still unknown.</p>
<p>Neither does the striatum play a critical role in the theory of aversive mood and emotion by <xref ref-type="bibr" rid="bibr37-1754073911421374">Depue and Lenzenweger (2005)</xref>, and <xref ref-type="bibr" rid="bibr31-1754073911421374">Cloninger, Svrakic, and Przybeck (1993)</xref>. Specifically, the striatum is not considered to be a critical site for anxiety (e.g., <xref ref-type="bibr" rid="bibr90-1754073911421374">Letwin et al., 2006</xref>), fear (e.g., <xref ref-type="bibr" rid="bibr25-1754073911421374">Calder, Lawrence, &amp; Young, 2001</xref>), or panic. In addition, cytokines, aside from IL-2, do not play a role in any of these theories. Thus, classical personality theories and empirical evidence do not address the combination between cytokines and anxiety in the striatum. Rather, the striatum (and particularly the nucleus accumbens within the ventral part of the striatum) is conceived to be involved in the realization of motivation into action. Until now the nucleus accumbens is often seen as a well-defined anatomical nucleus that is specialized to transfer limbic activities to the motor system. This is not at all unusual, since practically all major brain regions involved in emotional and motivational functions have a more or less direct relation to motor structures in the brainstem. Recent studies of connections, chemoarchitecture, and development of the basal forebrain of amphibians have revealed that mammalian and nonmammalian vertebrates share a common pattern of basal ganglia organization (<xref ref-type="bibr" rid="bibr151-1754073911421374">Smeets, Marín, &amp; González, 2000</xref>).</p>
<p>The basal ganglia as a whole are not viewed as important for the feeling of anxiety, fear, or panic, but for the execution of moving away from or towards danger. The only anxiety-related psychiatric condition that is consistently suggested to be related to the striatum is obsessive-compulsive disorder (e.g., <xref ref-type="bibr" rid="bibr65-1754073911421374">Graybiel &amp; Rauch, 2000</xref>; <xref ref-type="bibr" rid="bibr154-1754073911421374">Stein &amp; Stahl, 2000</xref>). Dysfunction of frontal-striatal, particularly orbitofrontal-striatal, circuitry has been implicated in the pathophysiology of obsessive-compulsive disorder independent of state anxiety and disease symptom severity (<xref ref-type="bibr" rid="bibr163-1754073911421374">van den Heuvel et al., 2005a</xref>). However, there are now studies even showing local microcircuits in the nucleus accumbens mediating motivated/affective behavior that is bivalently organized with negative and positive valence along rostrocaudal gradients (<xref ref-type="bibr" rid="bibr129-1754073911421374">Reynolds &amp; Berridge, 2002</xref>). Some resemblance to the present data stems also from depression research (e.g., reviewed by <xref ref-type="bibr" rid="bibr34-1754073911421374">Dantzer, O’Connor, Freund, Johnson, &amp; Kelley, 2008</xref>; <xref ref-type="bibr" rid="bibr127-1754073911421374">Raison, Capuron, &amp; Miller, 2006</xref>; <xref ref-type="bibr" rid="bibr170-1754073911421374">Wichers &amp; Maes, 2002</xref>).</p>
<p>In addition to previous studies (<xref ref-type="bibr" rid="bibr128-1754073911421374">Reiman et al., 1989</xref>; <xref ref-type="bibr" rid="bibr130-1754073911421374">Richard, Schiffer, &amp; Kurlan, 1996</xref>; <xref ref-type="bibr" rid="bibr177-1754073911421374">Wu et al., 1991</xref>), there are a number of very recent studies in rodents and humans that point to a role for the basal ganglia, especially for the striatum, in anxiety. The fact that the elevated plus-maze is considered as a model for anxiety and possibly learned phobic behavior when animals are tested again indicates the importance of the present results and related evidence recently published by other groups. Anxiety-like/avoidance behavior in animals was found to induce distinct patterns of activation of the immediate-early gene c-fos in the brains of high- and low-responding rats following a 5-minute exposure to an anxiogenic stressor (light–dark box). When compared to low responders, high-responding rats showed high c-fos mRNA levels in the dorsal striatum (<xref ref-type="bibr" rid="bibr80-1754073911421374">Kabbaj &amp; Akil, 2001</xref>). C-fos is used as an indirect marker of neuronal activity because it is often expressed when neurons fire action potentials, and it indicates recent activity. Furthermore, anxiety-like/avoidance behavior in an open field shown by higher center avoidance and corner preference in Connexin30-deficient mice was related to lower dopamine and metabolite levels in the ventral striatum (<xref ref-type="bibr" rid="bibr38-1754073911421374">Dere et al., 2003</xref>). Connexin proteins allow region-specific and cell-type dependent intercellular electrical and metabolic communication.</p>
<p>The results of <xref ref-type="bibr" rid="bibr168-1754073911421374">Weintraub et al. (2005)</xref> suggest an inverse correlation in patients with Parkinson disease compared to healthy individuals in the control condition with regard to the severity of depression and anxiety symptoms correlated with basal ganglia decreased dopamine function, specifically with regard to the left anterior putamen. They also found a substantial correlation between depression and anxiety, suggesting a common neurobiologic basis for these symptoms. If so, then it is possible that a given treatment may be effective for both symptoms. This would be consistent with existing research in patients without Parkinson’s disease showing that newer antidepressants have both antidepressant and antianxiety effects (<xref ref-type="bibr" rid="bibr159-1754073911421374">Tollefson &amp; Rosenbaum, 1998</xref>). A recent review on the aetiology and neurobiology of social anxiety disorder indicated that neuroanatomical areas implicated in social anxiety disorder include also the striatum (<xref ref-type="bibr" rid="bibr99-1754073911421374">Mathew &amp; Ho, 2006</xref>). This is in line with <xref ref-type="bibr" rid="bibr140-1754073911421374">Sareen et al. (2007)</xref>, who examined whether patients with generalized social phobia had differential activation in striatal regions compared with healthy individuals in the control condition while engaged in a cognitive task that has been shown to activate striatal regions. The generalized social phobia and healthy comparison participants were not different from each other in their test performance. However, patients with generalized social phobia showed reduced neural activation related to implicit learning compared with healthy comparison participants in the left caudate head assessed by functional magnetic resonance imaging (fMRI) (<xref ref-type="bibr" rid="bibr140-1754073911421374">Sareen et al., 2007</xref>). These results are supported by <xref ref-type="bibr" rid="bibr94-1754073911421374">Lorberbaum et al. (2004)</xref>, who observed that patients with generalized social phobia as opposed to healthy individuals in the control condition showed greater striatal activity in addition to other brain areas, during anticipation of a public speech.</p>
<p>High scores on two anxiety-related personality scales, somatic anxiety, and muscular tension, were significantly associated with low presynaptic dopamine synthesis capacity in the caudate in healthy participants (<xref ref-type="bibr" rid="bibr87-1754073911421374">Laakso et al., 2003</xref>). In addition, abusers of methamphetamine provided higher self-ratings of depression and anxiety than control subjects and showed higher relative regional glucose metabolism in the ventral striatum amongst other brain areas (<xref ref-type="bibr" rid="bibr93-1754073911421374">London et al., 2004</xref>).</p>
<p>Interesting, although contrary, data are also now available for fear and striatal functions. Rats lesioned in the dorsal striatum were not impaired in contextual fear conditioning but in tone fear conditioning. Both electrolytically and neurotoxically lesioned animals showed less freezing behavior compared with control rats (<xref ref-type="bibr" rid="bibr43-1754073911421374">Ferreira, Moreira, Ikeda, Bueno, &amp; Oliveira, 2003</xref>). In contrast, the group of Kandel did not show that the striatum is involved in learned safety by negatively correlating auditory conditioned stimuli with aversive events (<xref ref-type="bibr" rid="bibr137-1754073911421374">Rogan, Leon, Perez, &amp; Kandel, 2005</xref>). In addition, there were no differences found between contextual- or tone-cued conditioning fear responses of mice with selectively ablated cholinergic neurons in the striatum (<xref ref-type="bibr" rid="bibr85-1754073911421374">Kitabatake, Hikida, Watanabe, Pastan, &amp; Nakanishi, 2003</xref>). Finally, in an individual approach taken by <xref ref-type="bibr" rid="bibr141-1754073911421374">Schenberg et al. (2006)</xref>, rats were exposed to a contextual fear-conditioning task and were then classified as high or low responders according to performance. Out of 52 analyzed brain regions, NR2A gene expression was higher only in the dorsal striatum of low-performance rats, while no differences were shown in any of the other brain areas, or for NR2B.</p>
<p>Recently, <xref ref-type="bibr" rid="bibr164-1754073911421374">van den Heuvel et al. (2005b)</xref> investigated functional neural correlates and disease specificity of attentional bias across different anxiety disorders (e.g., panic) with a cognitive and emotional stress test (Stroop test). Their results suggest increased distractibility by irrelevant information in patients with panic disorder as compared to subjects in the control condition and this seems to involve ventral and widespread dorsal striatal brain regions.</p>
<p>Finally, in a series of fMRI experiments with healthy individuals, aversive conditioning using unpleasant cutaneous electrical stimulation was shown to reliably activate the ventral striatum (<xref ref-type="bibr" rid="bibr79-1754073911421374">Jensen et al., 2003</xref>). This activation was observed during anticipation and was not a consequence of relief after the aversive event. Further, the ventral striatum was activated in anticipation regardless of whether there was an opportunity to avoid the aversive stimulus or not. These data are supported by <xref ref-type="bibr" rid="bibr69-1754073911421374">Hasler et al. (2007)</xref>, who found that there are distinct neuronal networks involved in cued fear (e.g., bilateral putamen) and contextual anxiety (bilateral ventral striatum). Even more so, there is accumulating evidence supporting the role of the striatum for aversive outcomes (<xref ref-type="bibr" rid="bibr142-1754073911421374">Schiller, Levy, Niv, LeDoux, &amp; Phelps, 2008</xref>). Although striatal activation has been observed in aversive learning paradigm in humans (<xref ref-type="bibr" rid="bibr79-1754073911421374">Jensen et al., 2003</xref>) and animals (<xref ref-type="bibr" rid="bibr78-1754073911421374">Horvitz, 2000</xref>; <xref ref-type="bibr" rid="bibr146-1754073911421374">Schoenbaum &amp; Setlow, 2003</xref>), the role of this area of aversive learning is only beginning to be understood in normal and pathological aversive states. For example, it was demonstrated that regional activity in frontolimbic and striatal areas increased significantly, and connectivity among limbic and striatal networks was attenuated in participants who had recently experienced severe emotional trauma (<xref ref-type="bibr" rid="bibr96-1754073911421374">Lui et al., 2009</xref>).</p>
</sec>
<sec id="section13-1754073911421374">
<title>Suggestions for Future Research</title>
<p>At first sight, the elevated plus-maze appears to be thoroughly characterized and effective for understanding clinically relevant problems, but a number of issues remain to be addressed. One stems from the lack of sufficient studies on long-term effects of drugs. Another issue concerns a need for more precise validity of the elevated plus-maze for human disorders as postulated in general for animal tests by <xref ref-type="bibr" rid="bibr174-1754073911421374">Willner (1991)</xref>, and <xref ref-type="bibr" rid="bibr175-1754073911421374">Willner and Mitchell (2002)</xref>. In the future, the individual approach to study behavior of laboratory animals has to play a more important role than before. Thus, the introduced animal model of differential anxiety-like/avoidance behavior provides one critical method to develop a much needed individualized approach to the treatment of psychiatric disorders (<xref ref-type="bibr" rid="bibr112-1754073911421374">Pawlak et al., 2008</xref>) and other diseases (<xref ref-type="bibr" rid="bibr176-1754073911421374">Woodcock, 2007</xref>).</p>
<p>It may also be necessary to develop further animal models to examine hitherto unknown relationships concerning cognitive influences on emotional behavior that have not been systematically addressed in rodents. Recently, such an approach was established by a new ambiguous-cue interpretation paradigm and, with respect to the aetiology of depression, evaluated whether environmental and genetic factors contribute to a negative bias (<xref ref-type="bibr" rid="bibr39-1754073911421374">Enkel et al., 2010</xref>). Rats were trained to press a lever to receive a food reward contingent to one tone and to press another lever in response to a different tone in order to avoid punishment by electric foot shock. In the ambiguous-cue test, the lever-press responses to tones with frequencies intermediate to the trained tones were taken as indicators for the rats’ expectation of a positive or negative event (“glass half empty or half full?”). A negative response bias due to decreased positive and increased negative responding was found in congenitally helpless rats, a genetic animal model of depression (<xref ref-type="bibr" rid="bibr72-1754073911421374">Henn &amp; Vollmayr, 2005</xref>). Moreover, treatment with a combined noradrenergic-glucocorticoid challenge, mimicking stress-related changes in endogenous neuromodulation, biased rats away from positive responding. This response shift was accompanied by neuronal activation in dentate gyrus and amygdala (<xref ref-type="bibr" rid="bibr39-1754073911421374">Enkel et al., 2010</xref>).</p>
<p>As was ingeniously demonstrated by <xref ref-type="bibr" rid="bibr39-1754073911421374">Enkel et al. (2010)</xref>, animals alike to humans do not react in the same manner to an identical stimulus taking cognition into account. It is therefore a must to distinguish between individual subjects, and to select subgroups of animals in a given population that are particularly reactive and are thus readily induced into different emotional states than animals that are less responsive to external stimuli. These differential models are interesting with regard to anxiety and its potential treatments. In this respect it is necessary to incorporate evidence from animal personality research in order to gain better insight into differential mechanisms. In the end the usually great variance in putative similar animals is still one of the most neglected problems. As pointed out in this work, much of this variance is systematic in nature (<xref ref-type="bibr" rid="bibr60-1754073911421374">Gosling, 2001</xref>; <xref ref-type="bibr" rid="bibr112-1754073911421374">Pawlak et al., 2008</xref>).</p>
<p>It should also be a promising approach to combine this line of research by analyzing different behavioral subgroups and their quantitative trait loci (QTL), that is, indicating a significant relationship between the phenotype (e.g. anxiety-related behavior) and a genetic trait, of which the genomic location is known (<xref ref-type="bibr" rid="bibr42-1754073911421374">Fernández-Teruel et al., 2002</xref>). Moreover, current thinking holds that genotype has a substantial influence in determining personality traits (<xref ref-type="bibr" rid="bibr22-1754073911421374">Bouchard, 1994</xref>), although research has developed from assuming single gene causation in support to more complex polygenic models of personality traits (<xref ref-type="bibr" rid="bibr108-1754073911421374">Noblett &amp; Coccaro, 2005</xref>). In the field of behavioral genetics, a wide array of research tools is available to determine the role of genetics in behavior of laboratory animals. Research on genetically modified animals has increased dramatically over recent years. Overviews are given by <xref ref-type="bibr" rid="bibr24-1754073911421374">Bucán and Abel (2002)</xref>, <xref ref-type="bibr" rid="bibr30-1754073911421374">Clément, Calatayud, and Belzung (2002)</xref>, <xref ref-type="bibr" rid="bibr52-1754073911421374">Finn, Rutledge-Gorman, and Crabbe (2003)</xref>, <xref ref-type="bibr" rid="bibr53-1754073911421374">Flint (2003)</xref>, and <xref ref-type="bibr" rid="bibr66-1754073911421374">Gross and Hen (2004)</xref>. Even more, it has been possible to assess single genes or a conglomeration of genes that may be relevant for the expression of behavior also in humans.</p>
<p>We believe that an extended individualized approach in animal research is an optimal way to develop a personalized approach in biopsychosocial research and pathophysiology. The heterogeneity of psychiatric conditions (and other diseases) should be taken into account when further modeling behavior. For example, caution needs to be exerted when claiming a model to display the full construct. It should be clear that single existing behavioral tests or paradigms are not capable of displaying the wide array of a psychiatric condition or psychological state (e.g., anxiety). Often, we do not specify what type of anxiety (or any other psychological construct) we test in animals. Thus, a new generation of animal models and a more sophisticated and in-depth approach of existing behavioral tests are much needed to specifically mimic symptoms more in-depth in translational research. Hence, such work requires extensive communication between all disciplines.</p>
<p>Likewise, as shown in research with humans and experienced in encounters in daily life with humans, animals simply do not react uniformly to the same stimulus. It should be investigated in detail whether and how individual anxiety-like/avoidance behavior and activity levels affect the reactivity to anxiolytic drugs, since it may prove useful to get a better understanding of normal behavior and psychiatric conditions. Our novel approach of combining individual behavior, drugs (cytokines are becoming particularly interesting here), peripheral and central nervous processes is challenging, but will likely be of benefit in the long run for a better understanding. It is quite clear now that part of the psychopharmacological effects observed at behavioral levels is explained by the interference of behavioral traits, that is, by relations between the organism and its environment (<xref ref-type="bibr" rid="bibr112-1754073911421374">Pawlak et al., 2008</xref>). The appropriate term for such research by taking the individual into account is <italic>differential psychopharmacology</italic>. This term has been already used by <xref ref-type="bibr" rid="bibr17-1754073911421374">Boissier (1978)</xref>, and even earlier coined by <xref ref-type="bibr" rid="bibr131-1754073911421374">Richelle (1968)</xref>. This term denotes the fact that behavior should be treated in psychopharmacological research not only as a dependent variable, but, eventually, as an independent variable. In other words, in contrast to the traditional approaches in behavioral pharmacology, reactivity of drugs to personality in humans or behavioral traits in animals must be critically considered. The time is ripe to revitalize and extend this approach with fervour.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other">
<p>We are indebted to Dr. Rainer K.W. Schwarting and Dr. Ron Mucha for carefully revising an earlier version of this manuscript. Parts of this work were supported by the German Research Foundation (DFG PA 818/4-1).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Abramson</surname><given-names>L. Y.</given-names></name>
<name><surname>Seligman</surname><given-names>M. E. P.</given-names></name>
</person-group> (<year>1977</year>). <article-title>Modeling psychopathology in the laboratory: History and rationale</article-title>. In <person-group person-group-type="editor">
<name><surname>Maser</surname><given-names>J. D.</given-names></name>
<name><surname>Seligman</surname><given-names>M. E. P.</given-names></name>
</person-group> (Eds.), <source>Psychopathology: Experimental models</source> (pp. <fpage>1</fpage>–<lpage>26</lpage>). <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>Freeman</publisher-name>.</citation>
</ref>
<ref id="bibr2-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>S. S.</given-names></name>
<name><surname>Garcia</surname><given-names>R. A.</given-names></name>
<name><surname>de Oliveira</surname><given-names>L. M.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze</article-title>. <source>Physiology &amp; Behavior</source>, <volume>54</volume>, <fpage>749</fpage>–<lpage>752</lpage>.</citation>
</ref>
<ref id="bibr3-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>S. S.</given-names></name>
<name><surname>Tonkiss</surname><given-names>J.</given-names></name>
<name><surname>Galler</surname><given-names>J. R.</given-names></name>
</person-group> (<year>1996</year>). <article-title>Prenatal protein malnutrition affects exploratory behavior of female rats in the elevated plus-maze test</article-title>. <source>Physiology &amp; Behavior</source>, <volume>60</volume>, <fpage>675</fpage>–<lpage>680</lpage>.</citation>
</ref>
<ref id="bibr4-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Amelang</surname><given-names>M.</given-names></name>
<name><surname>Bartussek</surname><given-names>D.</given-names></name>
<name><surname>Stemmler</surname><given-names>G.</given-names></name>
<name><surname>Hagemann</surname><given-names>D.</given-names></name>
</person-group> (<year>2006</year>). <source>Differentielle Psychologie und Persönlichkeitsforschung</source> [<trans-source xml:lang="en">Differential psychology and personality research</trans-source>] (<edition>6th ed.</edition>). <publisher-loc>Stuttgart, Germany</publisher-loc>: <publisher-name>Kohlhammer</publisher-name>.</citation>
</ref>
<ref id="bibr5-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>M. M. M.</given-names></name>
<name><surname>Tomé</surname><given-names>M. F.</given-names></name>
<name><surname>Santiago</surname><given-names>E. S.</given-names></name>
<name><surname>Lúcia-Santos</surname><given-names>A.</given-names></name>
<name><surname>de Andrade</surname><given-names>T. G. C. S.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Longitudinal study of daily variation of rats’ behavior in the elevated plus-maze</article-title>. <source>Physiology &amp; Behavior</source>, <volume>78</volume>, <fpage>125</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr6-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andreatini</surname><given-names>R.</given-names></name>
<name><surname>Blanchard</surname><given-names>C.</given-names></name>
<name><surname>Blanchard</surname><given-names>R.</given-names></name>
<name><surname>Brandão</surname><given-names>M. L.</given-names></name>
<name><surname>Carobrez</surname><given-names>A. P.</given-names></name>
<name><surname>Griebel</surname><given-names>G.</given-names></name>
<name><surname>… Graeff</surname><given-names>F. G.</given-names></name>
</person-group> (<year>2001</year>). <article-title>The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis</article-title>. <source>Brazilian Journal of Medical and Biological Research</source>, <volume>34</volume>, <fpage>145</fpage>–<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr7-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andreatini</surname><given-names>R.</given-names></name>
<name><surname>Vital</surname><given-names>M. A. B. F.</given-names></name>
<name><surname>Santos</surname><given-names>G. L.</given-names></name>
</person-group> (<year>2003</year>). <article-title>The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus-maze</article-title>. <source>European Neuropsychopharmacology</source>, <volume>13</volume>, <issue>Suppl. 4</issue>, <fpage>378</fpage>–<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr8-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andrews</surname><given-names>N.</given-names></name>
<name><surname>File</surname><given-names>S. E.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety</article-title>. <source>European Journal of Pharmacology</source>, <volume>235</volume>, <fpage>109</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr9-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Barlow</surname><given-names>D. H.</given-names></name>
</person-group> (<year>2002</year>). <source>Anxiety and its disorders: The nature and treatment of anxiety and panic</source> (<edition>2nd ed.</edition>). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>.</citation>
</ref>
<ref id="bibr10-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bauhofer</surname><given-names>A.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Köster</surname><given-names>M.</given-names></name>
<name><surname>Schmitt</surname><given-names>A.</given-names></name>
<name><surname>Lorenz</surname><given-names>W.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials</article-title>. <source>Inflammation Research</source>, <volume>53</volume>, <fpage>697</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr11-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Binder</surname><given-names>E.</given-names></name>
<name><surname>Droste</surname><given-names>S. K.</given-names></name>
<name><surname>Ohl</surname><given-names>F.</given-names></name>
<name><surname>Reul</surname><given-names>J. M. H. M.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice</article-title>. <source>Behavioural Brain Research</source>, <volume>155</volume>, <fpage>197</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr12-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
</person-group> (<year>1988</year>). <article-title>Ethoexperimental approaches to the biology of emotion</article-title>. <source>Annual Review of Psychology</source>, <volume>39</volume>, <fpage>43</fpage>–<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr13-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
</person-group> (<year>1989</year>). <article-title>Antipredator defensive behaviors in a visible burrow system</article-title>. <source>Journal of Comparative Psychology</source>, <volume>103</volume>, <fpage>70</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr14-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
</person-group> (<year>1990</year>). <article-title>An ethoexperimental analysis of defense, fear and anxiety</article-title>. In <person-group person-group-type="editor">
<name><surname>McNaughton</surname><given-names>N.</given-names></name>
<name><surname>Andrews</surname><given-names>G.</given-names></name>
</person-group> (Eds.), <source>Anxiety</source> (pp. <fpage>124</fpage>–<lpage>133</lpage>). <publisher-loc>Dunedin, New Zealand</publisher-loc>: <publisher-name>Otago University Press</publisher-name>.</citation>
</ref>
<ref id="bibr15-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
<name><surname>Parmigiani</surname><given-names>S.</given-names></name>
<name><surname>Bjornson</surname><given-names>C.</given-names></name>
<name><surname>Masuda</surname><given-names>C.</given-names></name>
<name><surname>Weiss</surname><given-names>S. M.</given-names></name>
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
</person-group> (<year>1995</year>). <article-title>Antipredator behaviour of Swiss-Webster mice in a visible burrow system</article-title>. <source>Aggressive Behavior</source>, <volume>21</volume>, <fpage>123</fpage>–<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr16-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
<name><surname>Yudko</surname><given-names>E. B.</given-names></name>
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety</article-title>. <source>Behavioural Brain Research</source>, <volume>58</volume>, <fpage>155</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr17-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Boissier</surname><given-names>J. R.</given-names></name>
</person-group> (Ed.). (<year>1978</year>). <article-title>Differential psychopharmacology on anxiolytics and sedatives</article-title>. <source>Modern Trends in Pharmacopsychiatry</source>, <volume>14</volume>, <fpage>143</fpage>–<lpage>156</lpage>. <publisher-loc>Karger</publisher-loc>: <publisher-name>Basel</publisher-name>.</citation>
</ref>
<ref id="bibr18-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borsini</surname><given-names>F.</given-names></name>
<name><surname>Podhorna</surname><given-names>J.</given-names></name>
<name><surname>Marazziti</surname><given-names>D.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Do animal models of anxiety predict anxiolytic-like effects of antidepressants?</article-title> <source>Psychopharmacology</source>, <volume>163</volume>, <fpage>121</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr19-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borta</surname><given-names>A.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2005a</year>). <article-title>Inhibitory avoidance, pain reactivity, and plus-maze behaviour in Wistar rats with high versus low rearing activity</article-title>. <source>Physiology &amp; Behavior</source>, <volume>84</volume>, <fpage>387</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr20-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borta</surname><given-names>A.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2005b</year>). <article-title>Post-trial treatment with the nicotinic agonist metanicotine: Differential effects in Wistar rats with high versus low rearing activity</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>80</volume>, <fpage>541</fpage>–<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr21-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Borta</surname><given-names>A.</given-names></name>
<name><surname>Wöhr</surname><given-names>M.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior</article-title>. <source>Behavioural Brain Research</source>, <volume>166</volume>, <fpage>271</fpage>–<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr22-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bouchard</surname><given-names>T. J.</given-names><suffix>Jr.</suffix></name>
</person-group> (<year>1994</year>). <article-title>Genes, environment, and personality</article-title>. <source>Science</source>, <volume>264</volume>, <fpage>1700</fpage>–<lpage>1701</lpage>.</citation>
</ref>
<ref id="bibr23-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brioni</surname><given-names>J. D.</given-names></name>
<name><surname>Orsingher</surname><given-names>O. A.</given-names></name>
</person-group> (<year>1988</year>). <article-title>Operant behavior and reactivity to the anticonflict effect of diazepam in perinatally undernourished rats</article-title>. <source>Physiology &amp; Behavior</source>, <volume>44</volume>, <fpage>193</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr24-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bucán</surname><given-names>M.</given-names></name>
<name><surname>Abel</surname><given-names>T.</given-names></name>
</person-group> (<year>2002</year>). <article-title>The mouse: Genetics meets behaviour</article-title>. <source>Nature Reviews Genetics</source>, <volume>3</volume>, <fpage>114</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr25-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Calder</surname><given-names>A. J.</given-names></name>
<name><surname>Lawrence</surname><given-names>A. D.</given-names></name>
<name><surname>Young</surname><given-names>A. W.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Neuropsychology of fear and loathing</article-title>. <source>Nature Reviews Neuroscience</source>, <volume>2</volume>, <fpage>352</fpage>–<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr26-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Canto-de-Souza</surname><given-names>A.</given-names></name>
<name><surname>Nunes-de-Souza</surname><given-names>R. L.</given-names></name>
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: Influence of prior test experience</article-title>. <source>Brain Research</source>, <volume>928</volume>, <fpage>50</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr27-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Capitanio</surname><given-names>J. P.</given-names></name>
</person-group> (<year>1985</year>). <article-title>Early experience and social processes in rhesus macaques (<italic>Macaca mulatta</italic>): II. Complex social interaction</article-title>. <source>Journal of Comparative Psychology</source>, <volume>99</volume>, <fpage>133</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr28-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carobrez</surname><given-names>A. P.</given-names></name>
<name><surname>Bertoglio</surname><given-names>L. J.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>29</volume>, <fpage>1193</fpage>–<lpage>1205</lpage>.</citation>
</ref>
<ref id="bibr29-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carver</surname><given-names>C. S.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Impulse and constraint: Perspectives from personality psychology, convergence with theory in other areas, and potential for integration</article-title>. <source>Personality and Social Psychology Review</source>, <volume>9</volume>, <fpage>312</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr30-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clément</surname><given-names>Y.</given-names></name>
<name><surname>Calatayud</surname><given-names>F.</given-names></name>
<name><surname>Belzung</surname><given-names>C.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Genetic basis of anxiety-like behaviour: A critical review</article-title>. <source>Brain Research Bulletin</source>, <volume>57</volume>, <fpage>57</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr31-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cloninger</surname><given-names>C. R.</given-names></name>
<name><surname>Svrakic</surname><given-names>D. M.</given-names></name>
<name><surname>Przybeck</surname><given-names>T. R.</given-names></name>
</person-group> (<year>1993</year>). <article-title>A psychobiological model of temperament and character</article-title>. <source>Archives of General Psychiatry</source>, <volume>50</volume>, <fpage>975</fpage>–<lpage>990</lpage>.</citation>
</ref>
<ref id="bibr32-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crabbe</surname><given-names>J. C.</given-names></name>
<name><surname>Wahlsten</surname><given-names>D.</given-names></name>
<name><surname>Dudek</surname><given-names>B. C.</given-names></name>
</person-group> (<year>1999</year>). <article-title>Genetics of mouse behavior: Interactions with laboratory environment</article-title>. <source>Science</source>, <volume>284</volume>, <fpage>1670</fpage>–<lpage>1672</lpage>.</citation>
</ref>
<ref id="bibr33-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cruz-Morales</surname><given-names>S. E.</given-names></name>
<name><surname>Santos</surname><given-names>N. R.</given-names></name>
<name><surname>Brandão</surname><given-names>M. L.</given-names></name>
</person-group> (<year>2002</year>). <article-title>One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>72</volume>, <fpage>973</fpage>–<lpage>978</lpage>.</citation>
</ref>
<ref id="bibr34-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dantzer</surname><given-names>R.</given-names></name>
<name><surname>O’Connor</surname><given-names>J. C.</given-names></name>
<name><surname>Freund</surname><given-names>G. G.</given-names></name>
<name><surname>Johnson</surname><given-names>R. W.</given-names></name>
<name><surname>Kelley</surname><given-names>K. W.</given-names></name>
</person-group> (<year>2008</year>). <article-title>From inflammation to sickness and depression: When the immune system subjugates the brain</article-title>. <source>Nature Reviews Neuroscience</source>, <volume>9</volume>, <fpage>46</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr35-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>M.</given-names></name>
<name><surname>Walker</surname><given-names>D.</given-names></name>
<name><surname>Lee</surname><given-names>Y.</given-names></name>
</person-group> (<year>1997</year>). <article-title>Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD</article-title>. <source>Annals of the New York Academy of Sciences</source>, <volume>821</volume>, <fpage>305</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr36-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deakin</surname><given-names>J. F. W.</given-names></name>
<name><surname>Graeff</surname><given-names>F. G.</given-names></name>
</person-group> (<year>1991</year>). <article-title>5-HT and mechanisms of defence</article-title>. <source>Journal of Psychopharmacology</source>, <volume>5</volume>, <fpage>305</fpage>–<lpage>315</lpage>.</citation>
</ref>
<ref id="bibr37-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Depue</surname><given-names>R.</given-names></name>
<name><surname>Lenzenweger</surname><given-names>M.</given-names></name>
</person-group> (<year>2005</year>). <article-title>A neurobehavioral dimensional model of personality disturbance</article-title>. In <person-group person-group-type="editor">
<name><surname>Lenzenweger</surname><given-names>M.</given-names></name>
<name><surname>Clarkin</surname><given-names>J.</given-names></name>
</person-group> (Eds.), <source>Theories of personality disorders</source> (<edition>2nd ed.</edition>) (pp. <fpage>136</fpage>–<lpage>176</lpage>). <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>.</citation>
</ref>
<ref id="bibr38-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dere</surname><given-names>E.</given-names></name>
<name><surname>De Souza-Silva</surname><given-names>M. A.</given-names></name>
<name><surname>Frisch</surname><given-names>C.</given-names></name>
<name><surname>Teubner</surname><given-names>B.</given-names></name>
<name><surname>Söhl</surname><given-names>G.</given-names></name>
<name><surname>Willecke</surname><given-names>K.</given-names></name>
<name><surname>Huston</surname><given-names>J. P.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes</article-title>. <source>European Journal of Neuroscience</source>, <volume>18</volume>, <fpage>629</fpage>–<lpage>638</lpage>.</citation>
</ref>
<ref id="bibr39-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Enkel</surname><given-names>T.</given-names></name>
<name><surname>Gholizadeh</surname><given-names>D.</given-names></name>
<name><surname>von Bohlen und Halbach</surname><given-names>O.</given-names></name>
<name><surname>Sanchis-Segura</surname><given-names>C.</given-names></name>
<name><surname>Hurlemann</surname><given-names>R.</given-names></name>
<name><surname>Spanagel</surname><given-names>R.</given-names></name>
<name><surname>… Vollmayr</surname><given-names>B.</given-names></name>
</person-group> (<year>2010</year>). <article-title>Ambiguous-cue interpretation is biased under stress- and depression-like states in rats</article-title>. <source>Neuropsychopharmacology</source>, <volume>35</volume>, <fpage>1008</fpage>–<lpage>1015</lpage>.</citation>
</ref>
<ref id="bibr40-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fedotova</surname><given-names>J. O.</given-names></name>
<name><surname>Hartmann</surname><given-names>G.</given-names></name>
<name><surname>Lénárd</surname><given-names>L.</given-names></name>
<name><surname>Sapronov</surname><given-names>N. S.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Effects of 5-HT<sub>1A</sub> receptor agonist and antagonist on anxiety in intact and ovariectomized female rats</article-title>. <source>Acta Physiologica Hungarica</source>, <volume>91</volume>, <fpage>175</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr41-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>C.</given-names></name>
<name><surname>File</surname><given-names>S. E.</given-names></name>
</person-group> (<year>1996</year>). <article-title>The influence of open arm ledges and maze experience in the elevated plus-maze</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>54</volume>, <fpage>31</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr42-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fernández-Teruel</surname><given-names>A.</given-names></name>
<name><surname>Escorihuela</surname><given-names>R. M.</given-names></name>
<name><surname>Gray</surname><given-names>J. A.</given-names></name>
<name><surname>Aguilar</surname><given-names>R.</given-names></name>
<name><surname>Gil</surname><given-names>L.</given-names></name>
<name><surname>Giménez-Llort</surname><given-names>L.</given-names></name>
<name><surname>… Flint</surname><given-names>J.</given-names></name>
</person-group> (<year>2002</year>). <article-title>A quantitative trait locus influencing anxiety in the laboratory rat</article-title>. <source>Genome Research</source>, <volume>12</volume>, <fpage>618</fpage>–<lpage>626</lpage>.</citation>
</ref>
<ref id="bibr43-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>T. L.</given-names></name>
<name><surname>Moreira</surname><given-names>K. M.</given-names></name>
<name><surname>Ikeda</surname><given-names>D. C.</given-names></name>
<name><surname>Bueno</surname><given-names>O. F. A.</given-names></name>
<name><surname>Oliveira</surname><given-names>M. G. M.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Effects of dorsal striatum lesions in tone fear conditioning and contextual fear conditioning</article-title>. <source>Brain Research</source>, <volume>987</volume>, <fpage>17</fpage>–<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr44-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
</person-group> (<year>1990</year>). <article-title>One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze</article-title>. <source>Psychopharmacology</source>, <volume>100</volume>, <fpage>281</fpage>–<lpage>282</lpage>.</citation>
</ref>
<ref id="bibr45-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Factors controlling measures of anxiety and responses to novelty in the mouse</article-title>. <source>Behavioural Brain Research</source>, <volume>125</volume>, <fpage>151</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr46-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Andrews</surname><given-names>N.</given-names></name>
<name><surname>Wu</surname><given-names>P. Y.</given-names></name>
<name><surname>Zharkovsky</surname><given-names>A.</given-names></name>
<name><surname>Zangrossi</surname><given-names>H.</given-names><suffix>Jr.</suffix></name>
</person-group> (<year>1992</year>). <article-title>Modification of chlordiazepoxide’s behavioural and neurochemical effects by handling and plus-maze experience</article-title>. <source>European Journal of Pharmacology</source>, <volume>218</volume>, <fpage>9</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr47-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Gonzalez</surname><given-names>L. E.</given-names></name>
<name><surname>Gallant</surname><given-names>R.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Role of the basolateral nucleus of the amygdala in the formation of a phobia</article-title>. <source>Neuropsychopharmacology</source>, <volume>19</volume>, <fpage>397</fpage>–<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr48-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Kenny</surname><given-names>P. J.</given-names></name>
<name><surname>Cheeta</surname><given-names>S.</given-names></name>
</person-group> (<year>2000</year>). <article-title>The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety</article-title>. <source>Pharmacology Biochemistry and Behavior</source>, <volume>66</volume>, <fpage>65</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr49-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Mabbutt</surname><given-names>P. S.</given-names></name>
<name><surname>Hitchcott</surname><given-names>P.</given-names></name>
</person-group> (<year>1990</year>). <article-title>Characterisation of the phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze</article-title>. <source>Psychopharmacology</source>, <volume>102</volume>, <fpage>98</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr50-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Zangrossi</surname><given-names>H.</given-names><suffix>Jr.</suffix></name>
</person-group> (<year>1993</year>). <article-title>“One-trial tolerance” to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?</article-title> <source>Psychopharmacology</source>, <volume>110</volume>, <fpage>240</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr51-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Zangrossi</surname><given-names>H.</given-names><suffix>Jr.</suffix></name>
<name><surname>Viana</surname><given-names>M.</given-names></name>
<name><surname>Graeff</surname><given-names>F. G.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Trial 2 in the elevated plus-maze: A different form of fear?</article-title> <source>Psychopharmacology</source>, <volume>111</volume>, <fpage>491</fpage>–<lpage>494</lpage>.</citation>
</ref>
<ref id="bibr52-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Finn</surname><given-names>D. A.</given-names></name>
<name><surname>Rutledge-Gorman</surname><given-names>M. T.</given-names></name>
<name><surname>Crabbe</surname><given-names>J. C.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Genetic animal models of anxiety</article-title>. <source>Neurogenetics</source>, <volume>4</volume>, <fpage>109</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr53-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Flint</surname><given-names>J.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Analysis of quantitative trait loci that influence animal behavior</article-title>. <source>Journal of Neurobiology</source>, <volume>54</volume>, <fpage>46</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr54-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Francis</surname><given-names>R. C.</given-names></name>
</person-group> (<year>1990</year>). <article-title>Temperament in a fish: A longitudinal study of the development of individual differences in aggression and social rank in the Midas cichlid</article-title>. <source>Ethology</source>, <volume>86</volume>, <fpage>311</fpage>–<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr55-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frussa-Filho</surname><given-names>R.</given-names></name>
<name><surname>de Ribeiro</surname><given-names>R. A.</given-names></name>
</person-group> (<year>2002</year>). <article-title>One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure</article-title>. <source>Life Sciences</source>, <volume>71</volume>, <fpage>519</fpage>–<lpage>525</lpage>.</citation>
</ref>
<ref id="bibr56-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garbe</surname><given-names>C. M.</given-names></name>
<name><surname>Kemble</surname><given-names>E. D.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Effects of prior agonistic experience on risk assessment and approach behavior evoked by familiar and unfamiliar conspecific odors</article-title>. <source>Aggressive Behavior</source>, <volume>20</volume>, <fpage>143</fpage>–<lpage>149</lpage>.</citation>
</ref>
<ref id="bibr57-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>A. M. B.</given-names></name>
<name><surname>Cardenas</surname><given-names>F. P.</given-names></name>
<name><surname>Morato</surname><given-names>S.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Effect of different illumination levels on rat behavior in the elevated plus-maze</article-title>. <source>Physiology &amp; Behavior</source>, <volume>85</volume>, <fpage>265</fpage>–<lpage>270</lpage>.</citation>
</ref>
<ref id="bibr58-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gonzalez</surname><given-names>L. E.</given-names></name>
<name><surname>File</surname><given-names>S. E.</given-names></name>
</person-group> (<year>1997</year>). <article-title>A five minute experience in the elevated plus-maze alters the state of benzodiazepine receptor in the dorsal raphe nucleus</article-title>. <source>The Journal of Neuroscience</source>, <volume>17</volume>, <fpage>1505</fpage>–<lpage>1511</lpage>.</citation>
</ref>
<ref id="bibr59-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gosling</surname><given-names>S. D.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Personality dimensions in spotted hyenas (<italic>Crocuta crocuta</italic></article-title>). <source>Journal of Comparative Psychology</source>, <volume>112</volume>, <fpage>107</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr60-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gosling</surname><given-names>S. D.</given-names></name>
</person-group> (<year>2001</year>). <article-title>From mice to men: What can we learn about personality from animal research?</article-title> <source>Psychological Bulletin</source>, <volume>127</volume>, <fpage>45</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr61-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graeff</surname><given-names>F. G.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in animals</article-title>. <source>Brazilian Journal of Medical and Biological Research</source>, <volume>27</volume>, <fpage>811</fpage>–<lpage>829</lpage>.</citation>
</ref>
<ref id="bibr62-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graeff</surname><given-names>F. G.</given-names></name>
<name><surname>Guimarães</surname><given-names>F. S.</given-names></name>
<name><surname>De Andrade</surname><given-names>T. G. C. S.</given-names></name>
<name><surname>Deakin</surname><given-names>J. F. W.</given-names></name>
</person-group> (<year>1996</year>). <article-title>Role of 5-HT in stress, anxiety, and depression</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>54</volume>, <fpage>129</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr63-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>J. A.</given-names></name>
</person-group> (<year>1982</year>). <source>The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system</source> (<edition>1st ed.</edition>). <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr64-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Gray</surname><given-names>J. A.</given-names></name>
<name><surname>McNaughton</surname><given-names>N.</given-names></name>
</person-group> (<year>2000</year>). <source>The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system</source> (<edition>2nd ed.</edition>). <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr65-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graybiel</surname><given-names>A. M.</given-names></name>
<name><surname>Rauch</surname><given-names>S. L.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Toward a neurobiology of obsessive-compulsive disorder</article-title>. <source>Neuron</source>, <volume>28</volume>, <fpage>343</fpage>–<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr66-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gross</surname><given-names>C.</given-names></name>
<name><surname>Hen</surname><given-names>R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>The developmental origins of anxiety</article-title>. <source>Nature Reviews Neuroscience</source>, <volume>5</volume>, <fpage>545</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr67-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Halliday</surname><given-names>T. R.</given-names></name>
</person-group> (<year>1976</year>). <article-title>The libidinous newt: An analysis of variations in the sexual behaviour of the male smooth newt</article-title>, <source>Triturus vulgaris. Animal Behaviour</source>, <volume>24</volume>, <fpage>398</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr68-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Handley</surname><given-names>S. L.</given-names></name>
<name><surname>McBlane</surname><given-names>J. W.</given-names></name>
</person-group> (<year>1993</year>). <article-title>5-HT drugs in animal models of anxiety</article-title>. <source>Psychopharmacology</source>, <volume>112</volume>, <fpage>13</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr69-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasler</surname><given-names>G.</given-names></name>
<name><surname>Fromm</surname><given-names>S.</given-names></name>
<name><surname>Alvarez</surname><given-names>R. P.</given-names></name>
<name><surname>Luckenbaugh</surname><given-names>D. A.</given-names></name>
<name><surname>Drevets</surname><given-names>W. C.</given-names></name>
<name><surname>Grillon</surname><given-names>C.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Cerebral blood flow in immediate and sustained anxiety</article-title>. <source>The Journal of Neuroscience</source>, <volume>27</volume>, <fpage>6313</fpage>–<lpage>6319</lpage>.</citation>
</ref>
<ref id="bibr70-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasuo</surname><given-names>C.</given-names></name>
</person-group> (<year>1935</year>). <article-title>Effects of milieu upon character: I. Experiments with young chickens</article-title>. <source>Japanese Journal of Experimental Psychology</source>, <volume>2</volume>, <fpage>109</fpage>–<lpage>118</lpage>.</citation>
</ref>
<ref id="bibr71-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hebb</surname><given-names>D. O.</given-names></name>
</person-group> (<year>1949</year>). <article-title>Temperament in chimpanzees: I. Method and analyses</article-title>. <source>The Journal of Comparative and Physiological Psychology</source>, <volume>42</volume>, <fpage>192</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr72-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henn</surname><given-names>F. A.</given-names></name>
<name><surname>Vollmayr</surname><given-names>B.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Stress models of depression: Forming genetically vulnerable strains</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>29</volume>, <fpage>799</fpage>–<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr73-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Eichendorff</surname><given-names>J.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Individual response profiles of male Wistar rats in animal models for anxiety and depression</article-title>. <source>Behavioural Brain Research</source>, <volume>136</volume>, <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr74-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat</article-title>. <source>Behavioural Brain Research</source>, <volume>149</volume>, <fpage>135</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr75-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Wang</surname><given-names>C. F.</given-names></name>
<name><surname>Hsu</surname><given-names>W. Y.</given-names></name>
<name><surname>Tseng</surname><given-names>T.</given-names></name>
<name><surname>Hsu</surname><given-names>C. C.</given-names></name>
<name><surname>Kao</surname><given-names>M. D.</given-names></name>
<name><surname>Tsai</surname><given-names>Y. F.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Psychoimmunological effects of dioscorea in ovariectomized rats: Role of anxiety level</article-title>. <source>Annals of General Psychiatry</source>, <volume>6</volume>, <fpage>21</fpage>, doi:10.1186/1744-859X-6-21<pub-id pub-id-type="doi">10.1186/1744-859X-6-21</pub-id></citation>
</ref>
<ref id="bibr76-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hogg</surname><given-names>S.</given-names></name>
</person-group> (<year>1996</year>). <article-title>A review of the validity and variability of the elevated plus-maze as an animal model of anxiety</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>54</volume>, <fpage>21</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr77-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holmes</surname><given-names>A.</given-names></name>
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for a qualitative shift in emotional state?</article-title> <source>Pharmacology, Biochemistry and Behavior</source>, <volume>60</volume>, <fpage>473</fpage>–<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr78-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Horvitz</surname><given-names>J. C.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events</article-title>. <source>Neuroscience</source>, <volume>96</volume>, <fpage>651</fpage>–<lpage>656</lpage>.</citation>
</ref>
<ref id="bibr79-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>J.</given-names></name>
<name><surname>McIntosh</surname><given-names>A. R.</given-names></name>
<name><surname>Crawley</surname><given-names>A. P.</given-names></name>
<name><surname>Mikulis</surname><given-names>D. J.</given-names></name>
<name><surname>Remington</surname><given-names>G.</given-names></name>
<name><surname>Kapur</surname><given-names>S.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Direct activation of the ventral striatum in anticipation of aversive stimuli</article-title>. <source>Neuron</source>, <volume>40</volume>, <fpage>1251</fpage>–<lpage>1257</lpage>.</citation>
</ref>
<ref id="bibr80-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kabbaj</surname><given-names>M.</given-names></name>
<name><surname>Akil</surname><given-names>H.</given-names></name>
</person-group> (<year>2001</year>). <article-title>Individual differences in novelty-seeking behavior in rats: A c-fos study</article-title>. <source>Neuroscience</source>, <volume>106</volume>, <fpage>535</fpage>–<lpage>545</lpage>.</citation>
</ref>
<ref id="bibr81-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaesermann</surname><given-names>H. P.</given-names></name>
</person-group> (<year>1986</year>). <article-title>Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action</article-title>. <source>Psychopharmacology</source>, <volume>89</volume>, <fpage>31</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr82-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karl</surname><given-names>T.</given-names></name>
<name><surname>Pabst</surname><given-names>R.</given-names></name>
<name><surname>von Hörsten</surname><given-names>S.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Behavioral phenotyping of mice in pharmacological and toxicological research</article-title>. <source>Experimental and Toxicologic Pathology</source>, <volume>55</volume>, <fpage>69</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr83-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karrenbauer</surname><given-names>B. D.</given-names></name>
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Ludwig</surname><given-names>V.</given-names></name>
<name><surname>Löhn</surname><given-names>J.</given-names></name>
<name><surname>Spanagel</surname><given-names>R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Time-dependent effects of striatal interleukin-2 on open field behaviour in rats</article-title>. <source>Journal of Neuroimmunology</source>, <volume>208</volume>, <fpage>10</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr84-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>A. A.</given-names></name>
<name><surname>Jacobson</surname><given-names>K. C.</given-names></name>
<name><surname>Gardner</surname><given-names>C. O.</given-names></name>
<name><surname>Prescott</surname><given-names>C. A.</given-names></name>
<name><surname>Kendler</surname><given-names>K. S.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Personality and comorbidity of common psychiatric disorders</article-title>. <source>British Journal of Psychiatry</source>, <volume>186</volume>, <fpage>190</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr85-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kitabatake</surname><given-names>Y.</given-names></name>
<name><surname>Hikida</surname><given-names>T.</given-names></name>
<name><surname>Watanabe</surname><given-names>D.</given-names></name>
<name><surname>Pastan</surname><given-names>I.</given-names></name>
<name><surname>Nakanishi</surname><given-names>S.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Impairment of reward-related learning by cholinergic cell ablation in the striatum</article-title>. <source>Proceedings of the National Academy of Sciences, USA</source>, <volume>100</volume>, <fpage>7965</fpage>–<lpage>7970</lpage>.</citation>
</ref>
<ref id="bibr86-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kõks</surname><given-names>S.</given-names></name>
<name><surname>Beljajev</surname><given-names>S.</given-names></name>
<name><surname>Koovit</surname><given-names>I.</given-names></name>
<name><surname>Abramov</surname><given-names>U.</given-names></name>
<name><surname>Bourin</surname><given-names>M.</given-names></name>
<name><surname>Vasar</surname><given-names>E.</given-names></name>
</person-group> (<year>2001</year>). <article-title>8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze</article-title>. <source>Psychopharmacology</source>, <volume>153</volume>, <fpage>365</fpage>–<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr87-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Laakso</surname><given-names>A.</given-names></name>
<name><surname>Wallius</surname><given-names>E.</given-names></name>
<name><surname>Kajander</surname><given-names>J.</given-names></name>
<name><surname>Bergman</surname><given-names>J.</given-names></name>
<name><surname>Eskola</surname><given-names>O.</given-names></name>
<name><surname>Solin</surname><given-names>O.</given-names></name>
<name><surname>… Hietala</surname><given-names>J.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Personality traits and striatal dopamine synthesis capacity in healthy subjects</article-title>. <source>American Journal of Psychiatry</source>, <volume>160</volume>, <fpage>904</fpage>–<lpage>910</lpage>.</citation>
</ref>
<ref id="bibr88-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lathe</surname><given-names>R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>The individuality of mice</article-title>. <source>Genes, Brain and Behavior</source>, <volume>3</volume>, <fpage>317</fpage>–<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr89-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>LeDoux</surname><given-names>J. E.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Emotion circuits in the brain</article-title>. <source>Annual Review of Neuroscience</source>, <volume>23</volume>, <fpage>155</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr90-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Letwin</surname><given-names>N. E.</given-names></name>
<name><surname>Kafkafi</surname><given-names>N.</given-names></name>
<name><surname>Benjamini</surname><given-names>Y.</given-names></name>
<name><surname>Mayo</surname><given-names>C.</given-names></name>
<name><surname>Frank</surname><given-names>B. C.</given-names></name>
<name><surname>Luu</surname><given-names>T.</given-names></name>
<name><surname>… Elmer</surname><given-names>G. I.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene–behaviour associations</article-title>. <source>The Journal of Neuroscience</source>, <volume>26</volume>, <fpage>5277</fpage>–<lpage>5287</lpage>.</citation>
</ref>
<ref id="bibr91-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liebsch</surname><given-names>G.</given-names></name>
<name><surname>Wotjak</surname><given-names>C. T.</given-names></name>
<name><surname>Landgraf</surname><given-names>R.</given-names></name>
<name><surname>Engelmann</surname><given-names>M.</given-names></name>
</person-group> (<year>1996</year>). <article-title>Septal vasopressin modulates anxiety-related behaviour in rats</article-title>. <source>Neuroscience Letters</source>, <volume>217</volume>, <fpage>101</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr92-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lister</surname><given-names>R. G.</given-names></name>
</person-group> (<year>1987</year>). <article-title>The use of a plus-maze to measure anxiety in the mouse</article-title>. <source>Psychopharmacology</source>, <volume>92</volume>, <fpage>180</fpage>–<lpage>185</lpage>.</citation>
</ref>
<ref id="bibr93-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>London</surname><given-names>E. D.</given-names></name>
<name><surname>Simon</surname><given-names>S. L.</given-names></name>
<name><surname>Berman</surname><given-names>S. M.</given-names></name>
<name><surname>Mandelkern</surname><given-names>M. A.</given-names></name>
<name><surname>Lichtman</surname><given-names>A. M.</given-names></name>
<name><surname>Bramen</surname><given-names>J.</given-names></name>
<name><surname>… Ling</surname><given-names>W.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers</article-title>. <source>Archives of General Psychiatry</source>, <volume>61</volume>, <fpage>73</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr94-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorberbaum</surname><given-names>J. P.</given-names></name>
<name><surname>Kose</surname><given-names>S.</given-names></name>
<name><surname>Johnson</surname><given-names>M. R.</given-names></name>
<name><surname>Arana</surname><given-names>G. W.</given-names></name>
<name><surname>Sullivan</surname><given-names>L. K.</given-names></name>
<name><surname>Hamner</surname><given-names>M. B.</given-names></name>
<name><surname>… George</surname><given-names>M. S.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Neural correlates of speech anticipatory anxiety in generalized social phobia</article-title>. <source>Neuroreport</source>, <volume>15</volume>, <fpage>2701</fpage>–<lpage>2705</lpage>.</citation>
</ref>
<ref id="bibr95-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ludwig</surname><given-names>V.</given-names></name>
<name><surname>Mihov</surname><given-names>Y.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: Role of individual differences in anxiety-related behavior</article-title>. <source>Behavioural Brain Research</source>, <volume>189</volume>, <fpage>52</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr96-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lui</surname><given-names>S.</given-names></name>
<name><surname>Huang</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Tang</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>… Gong</surname><given-names>Q.</given-names></name>
</person-group> (<year>2009</year>). <article-title>High-field MRI reveals an acute impact on brain function in survivors of the magnitude 8.0 earthquake in China</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>106</volume>, <fpage>15412</fpage>–<lpage>15417</lpage>.</citation>
</ref>
<ref id="bibr97-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Marks</surname><given-names>I. M.</given-names></name>
</person-group> (<year>1987</year>). <source>Fears, phobias, and rituals: Panic, anxiety, and their disorders</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr98-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marks</surname><given-names>I. M.</given-names></name>
<name><surname>Nesse</surname><given-names>R. M.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Fear and fitness: An evolutionary analysis of anxiety disorders</article-title>. <source>Ethology and Sociobiology</source>, <volume>15</volume>, <fpage>147</fpage>–<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr99-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mathew</surname><given-names>S. J.</given-names></name>
<name><surname>Ho</surname><given-names>S.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Etiology and neurobiology of social anxiety disorder</article-title>. <source>Journal of Clinical Psychiatry</source>, <volume>67</volume>, <issue>Suppl. 12</issue>, <fpage>9</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr100-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McKinney</surname><given-names>W. T.</given-names><suffix>Jr.</suffix></name>
<name><surname>Bunney</surname><given-names>W. E.</given-names><suffix>Jr.</suffix></name>
</person-group> (<year>1969</year>). <article-title>Animal models of depression: I. Review of evidence: Implications for research</article-title>. <source>Archives of General Psychiatry</source>, <volume>21</volume>, <fpage>240</fpage>–<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr101-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNaughton</surname><given-names>N.</given-names></name>
<name><surname>Corr</surname><given-names>P. J.</given-names></name>
</person-group> (<year>2004</year>). <article-title>A two-dimensional neuropsychology of defense: Fear/anxiety and defensive distance</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>28</volume>, <fpage>285</fpage>–<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr102-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehta</surname><given-names>P. H.</given-names></name>
<name><surname>Gosling</surname><given-names>S. D.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Bridging human and animal research: A comparative approach to studies of personality and health</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>22</volume>, <fpage>651</fpage>–<lpage>661</lpage>.</citation>
</ref>
<ref id="bibr103-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Millan</surname><given-names>M. J.</given-names></name>
</person-group> (<year>2003</year>). <article-title>The neurobiology and control of anxious states</article-title>. <source>Progress in Neurobiology</source>, <volume>70</volume>, <fpage>83</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr104-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Molewijk</surname><given-names>H. E.</given-names></name>
<name><surname>van der Poel</surname><given-names>A. M.</given-names></name>
<name><surname>Olivier</surname><given-names>B.</given-names></name>
</person-group> (<year>1995</year>). <article-title>The ambivalent behaviour “stretched approach posture” as a paradigm to characterize anxiolytic drugs</article-title>. <source>Psychopharmacology</source>, <volume>121</volume>, <fpage>81</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr105-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montgomery</surname><given-names>K. C.</given-names></name>
</person-group> (<year>1955</year>). <article-title>The relation between fear induced by novel stimulation and exploratory behaviour</article-title>. <source>The Journal of Comparative and Physiological Psychology</source>, <volume>48</volume>, <fpage>254</fpage>–<lpage>260</lpage>.</citation>
</ref>
<ref id="bibr106-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morris</surname><given-names>P. H.</given-names></name>
<name><surname>Gale</surname><given-names>A.</given-names></name>
<name><surname>Duffy</surname><given-names>K.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Can judges agree on the personality of horses?</article-title> <source>Personality and Individual Differences</source>, <volume>33</volume>, <fpage>67</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr107-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Motta</surname><given-names>V.</given-names></name>
<name><surname>Maisonnette</surname><given-names>S.</given-names></name>
<name><surname>Morato</surname><given-names>S.</given-names></name>
<name><surname>Castrechini</surname><given-names>P.</given-names></name>
<name><surname>Brandão</surname><given-names>M. L.</given-names></name>
</person-group> (<year>1992</year>). <article-title>Effects of blockade of 5-HT2 receptors and activation of 5-HT<sub>1A</sub> receptors on the exploratory activity of rats in the elevated plus-maze</article-title>. <source>Psychopharmacology</source>, <volume>107</volume>, <fpage>135</fpage>–<lpage>139</lpage>.</citation>
</ref>
<ref id="bibr108-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Noblett</surname><given-names>K. L.</given-names></name>
<name><surname>Coccaro</surname><given-names>E. F.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Molecular genetics of personality</article-title>. <source>Current Psychiatry Reports</source>, <volume>7</volume>, <fpage>73</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr109-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nunes-de-Souza</surname><given-names>R. L.</given-names></name>
<name><surname>Canto-de-Souza</surname><given-names>A.</given-names></name>
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience</article-title>. <source>Brain Research</source>, <volume>927</volume>, <fpage>87</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr110-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohl</surname><given-names>F.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Testing for anxiety</article-title>. <source>Clinical Neuroscience Research</source>, <volume>3</volume>, <fpage>233</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr111-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Panksepp</surname><given-names>J.</given-names></name>
</person-group> (<year>1998</year>). <source>Affective neuroscience: The foundations of human and animal emotions</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr112-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Animal models of human psychopathology based on individual differences in novelty-seeking and anxiety</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>32</volume>, <fpage>1544</fpage>–<lpage>1568</lpage>.</citation>
</ref>
<ref id="bibr113-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Bauhofer</surname><given-names>A.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat</article-title>. <source>Neuroscience Letters</source>, <volume>341</volume>, <fpage>205</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr114-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Object preference and nicotine consumption in rats with high vs. low rearing activity in a novel open field</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>73</volume>, <fpage>679</fpage>–<lpage>687</lpage>.</citation>
</ref>
<ref id="bibr115-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2006a</year>). <article-title>Striatal microinjections of interleukin-2 and rat behaviour in the elevated plus-maze</article-title>. <source>Behavioural Brain Research</source>, <volume>168</volume>, <fpage>339</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr116-1754073911421374">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>2006b</year>). <article-title>Interleukin-2 in the striatum affects motivated open field behaviour in rats. Program No. A078.7. 2006 Abstract Viewer/Itinerary Planner</article-title>. <comment>Abstract retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKey=%7bDED5B473-0476-446A-8ECB-C77B2E89DAA6%7d&amp;SKey=%7b9F46C125-548B-4C4F-9017-B8897EEB622E%7d&amp;MKey=%7bD1974E76-28AF-4C1C-8AE8-4F73B56247A7%7d&amp;AKey=%7b3A7DC0B9-D787-44AA-BD08-FA7BB2FE9004%7d">http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKey=%7bDED5B473-0476-446A-8ECB-C77B2E89DAA6%7d&amp;SKey=%7b9F46C125-548B-4C4F-9017-B8897EEB622E%7d&amp;MKey=%7bD1974E76-28AF-4C1C-8AE8-4F73B56247A7%7d&amp;AKey=%7b3A7DC0B9-D787-44AA-BD08-FA7BB2FE9004%7d</ext-link></comment></citation>
</ref>
<ref id="bibr117-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Bauhofer</surname><given-names>A.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Cytokine mRNA levels in brain and peripheral tissues of the rat: Relationships with plus-maze behavior</article-title>. <source>Molecular Brain Research</source>, <volume>137</volume>, <fpage>159</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr118-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Weyers</surname><given-names>P.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Tiermodelle für Angst und Angststörungen. Ausgewählte Modelle und Ansätze zur Untersuchung individueller Differenzen</article-title> [<trans-title xml:lang="en">Animal models for anxiety and anxiety disorders – Selected models and approaches to study individual differences</trans-title>]. <source>Psychologische Rundschau</source>, <volume>57</volume>, <fpage>139</fpage>–<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr119-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pellow</surname><given-names>S.</given-names></name>
<name><surname>Chopin</surname><given-names>P.</given-names></name>
<name><surname>File</surname><given-names>S. E.</given-names></name>
<name><surname>Briley</surname><given-names>M.</given-names></name>
</person-group> (<year>1985</year>). <article-title>Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat</article-title>. <source>Journal of Neuroscience Methods</source>, <volume>14</volume>, <fpage>149</fpage>–<lpage>167</lpage>.</citation>
</ref>
<ref id="bibr120-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>J. K. D.</given-names></name>
<name><surname>Vieira</surname><given-names>R. J.</given-names></name>
<name><surname>Konishi</surname><given-names>C. T.</given-names></name>
<name><surname>de Ribeiro</surname><given-names>R. A.</given-names></name>
<name><surname>Frussa-Filho</surname><given-names>A.</given-names></name>
</person-group> (<year>1999</year>). <article-title>The phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation</article-title>. <source>Life Sciences</source>, <volume>65</volume>, <fpage>PL101</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr121-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Perkins</surname><given-names>A. M.</given-names></name>
<name><surname>Ettinger</surname><given-names>U.</given-names></name>
<name><surname>Davis</surname><given-names>R.</given-names></name>
<name><surname>Foster</surname><given-names>R.</given-names></name>
<name><surname>Williams</surname><given-names>S. C. R.</given-names></name>
<name><surname>Corr</surname><given-names>P. J.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Effects of Lorazepam and citalopram on human defensive reactions: Ethopharmacological differentiation of fear and anxiety</article-title>. <source>The Journal of Neuroscience</source>, <volume>29</volume>, <fpage>12617</fpage>–<lpage>12624</lpage>.</citation>
</ref>
<ref id="bibr122-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petitto</surname><given-names>J. M.</given-names></name>
<name><surname>Lysle</surname><given-names>D. T.</given-names></name>
<name><surname>Gariepy</surname><given-names>J.</given-names></name>
<name><surname>Lewis</surname><given-names>M. H.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Association of genetic differences in social behavior and cellular immune responsiveness: Effects of social experience</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>8</volume>, <fpage>111</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr123-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petitto</surname><given-names>J. M.</given-names></name>
<name><surname>Lysle</surname><given-names>D. T.</given-names></name>
<name><surname>Gariepy</surname><given-names>J.</given-names></name>
<name><surname>Clubb</surname><given-names>P. H.</given-names></name>
<name><surname>Cairns</surname><given-names>R. L.</given-names></name>
<name><surname>Lewis</surname><given-names>M. H.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Genetic differences in social behavior: Relation to natural killer cell function and susceptibility to tumor development</article-title>. <source>Neuropsychopharmacology</source>, <volume>8</volume>, <fpage>35</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr124-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Phelps</surname><given-names>E. A.</given-names></name>
<name><surname>LeDoux</surname><given-names>J. E.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Contributions of the amygdala to emotion processing: From animal models to human behavior</article-title>. <source>Neuron</source>, <volume>48</volume>, <fpage>175</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr125-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Pinel</surname><given-names>J. P. J.</given-names></name>
<name><surname>Mana</surname><given-names>M. J.</given-names></name>
</person-group> (<year>1989</year>). <article-title>Adaptive interactions of rats with dangerous inanimate objects: Support for a cognitive theory of defensive behavior</article-title>. In <person-group person-group-type="editor">
<name><surname>Blanchard</surname><given-names>R. J.</given-names></name>
<name><surname>Brain</surname><given-names>P. F.</given-names></name>
<name><surname>Parmigiani</surname><given-names>S.</given-names></name>
<name><surname>Blanchard</surname><given-names>D. C.</given-names></name>
</person-group> (Eds.), <source>Ethoexperimental approaches to the study of behavior</source> (pp. <fpage>137</fpage>–<lpage>150</lpage>). <publisher-loc>Dordrecht, The Netherlands</publisher-loc>: <publisher-name>Kluwer Academic Publishers</publisher-name>.</citation>
</ref>
<ref id="bibr126-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pinel</surname><given-names>J. P. J.</given-names></name>
<name><surname>Treit</surname><given-names>D.</given-names></name>
</person-group> (<year>1978</year>). <article-title>Burying as a defensive response in rats</article-title>. <source>The Journal of Comparative and Physiological Psychology</source>, <volume>92</volume>, <fpage>708</fpage>–<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr127-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raison</surname><given-names>C. L.</given-names></name>
<name><surname>Capuron</surname><given-names>L.</given-names></name>
<name><surname>Miller</surname><given-names>A. H.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Cytokines sing the blues: Inflammation and the pathogenesis of depression</article-title>. <source>Trends in Immunology</source>, <volume>27</volume>, <fpage>24</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr128-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reiman</surname><given-names>E. M.</given-names></name>
<name><surname>Raichle</surname><given-names>M. E.</given-names></name>
<name><surname>Robins</surname><given-names>E.</given-names></name>
<name><surname>Mintun</surname><given-names>M. A.</given-names></name>
<name><surname>Fusselman</surname><given-names>M. J.</given-names></name>
<name><surname>Fox</surname><given-names>P. T.</given-names></name>
<name><surname>… Hackman</surname><given-names>K. A.</given-names></name>
</person-group> (<year>1989</year>). <article-title>Neuroanatomical correlates of a lactate-induced anxiety attack</article-title>. <source>Archives of General Psychiatry</source>, <volume>46</volume>, <fpage>493</fpage>–<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr129-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reynolds</surname><given-names>S. M.</given-names></name>
<name><surname>Berridge</surname><given-names>K. C.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Positive and negative motivation in nucleus accumbens shell: Bivalent rostrocaudal gradients for GABA-elicited eating, taste “liking”/“disliking” reactions, place preference/avoidance, and fear</article-title>. <source>The Journal of Neuroscience</source>, <volume>22</volume>, <fpage>7308</fpage>–<lpage>7320</lpage>.</citation>
</ref>
<ref id="bibr130-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richard</surname><given-names>I. H.</given-names></name>
<name><surname>Schiffer</surname><given-names>R. B.</given-names></name>
<name><surname>Kurlan</surname><given-names>R.</given-names></name>
</person-group> (<year>1996</year>). <article-title>Anxiety and Parkinson’s disease</article-title>. <source>The Journal of Neuropsychiatry and Clinical Neurosciences</source>, <volume>8</volume>, <fpage>383</fpage>–<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr131-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Richelle</surname><given-names>M.</given-names></name>
</person-group> (<year>1968</year>). <article-title>The integration of behavior as a variable in psychopharmacological research</article-title>. <source>Journal of Physiology (Paris)</source>, <volume>60</volume>, <issue>Suppl. 1</issue>, <fpage>149</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr132-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
</person-group> (<year>1997</year>). <article-title>Animal models of “anxiety”: Where next?</article-title> <source>Behavioural Pharmacology</source>, <volume>8</volume>, <fpage>477</fpage>–<lpage>496</lpage>.</citation>
</ref>
<ref id="bibr133-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
<name><surname>Cao</surname><given-names>B. J.</given-names></name>
<name><surname>Dalvi</surname><given-names>A.</given-names></name>
<name><surname>Holmes</surname><given-names>A.</given-names></name>
</person-group> (<year>1997</year>). <article-title>Animal models of anxiety: An ethological perspective</article-title>. <source>Brazilian Journal of Medical and Biological Research</source>, <volume>30</volume>, <fpage>289</fpage>–<lpage>304</lpage>.</citation>
</ref>
<ref id="bibr134-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
<name><surname>Cole</surname><given-names>J. C.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Influence of social isolation, gender, strain and prior novelty on plus-maze behaviour in mice</article-title>. <source>Physiology &amp; Behavior</source>, <volume>54</volume>, <fpage>729</fpage>–<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr135-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
<name><surname>Lee</surname><given-names>C.</given-names></name>
<name><surname>Shepherd</surname><given-names>J. K.</given-names></name>
</person-group> (<year>1992</year>). <article-title>Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience</article-title>. <source>Psychopharmacology</source>, <volume>106</volume>, <fpage>102</fpage>–<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr136-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodgers</surname><given-names>R. J.</given-names></name>
<name><surname>Shepherd</surname><given-names>J. K.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice</article-title>. <source>Psychopharmacology</source>, <volume>113</volume>, <fpage>237</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr137-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rogan</surname><given-names>M. T.</given-names></name>
<name><surname>Leon</surname><given-names>K. S.</given-names></name>
<name><surname>Perez</surname><given-names>D. L.</given-names></name>
<name><surname>Kandel</surname><given-names>E. R.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Distinct neural signatures for safety and danger in the amygdala and striatum of the mouse</article-title>. <source>Neuron</source>, <volume>46</volume>, <fpage>309</fpage>–<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr138-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santucci</surname><given-names>L. B.</given-names></name>
<name><surname>Daud</surname><given-names>M. M.</given-names></name>
<name><surname>Almeida</surname><given-names>S. S.</given-names></name>
<name><surname>de Oliveira</surname><given-names>L. M.</given-names></name>
</person-group> (<year>1994</year>). <article-title>Effects of early protein malnutrition and environmental stimulation upon the reactivity to diazepam in two animal models of anxiety</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>49</volume>, <fpage>393</fpage>–<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr139-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sapolsky</surname><given-names>R. M.</given-names></name>
<name><surname>Ray</surname><given-names>J. C.</given-names></name>
</person-group> (<year>1989</year>). <article-title>Styles of dominance and their endocrine correlates among wild olive baboons (<italic>Pabio anubis</italic>)</article-title>. <source>American Journal of Primatology</source>, <volume>18</volume>, <fpage>1</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr140-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sareen</surname><given-names>J.</given-names></name>
<name><surname>Campbell</surname><given-names>D. W.</given-names></name>
<name><surname>Leslie</surname><given-names>W. D.</given-names></name>
<name><surname>Malisza</surname><given-names>K. L.</given-names></name>
<name><surname>Stein</surname><given-names>M. B.</given-names></name>
<name><surname>Paulus</surname><given-names>M. P.</given-names></name>
<name><surname>… Reiss</surname><given-names>J. P.</given-names></name>
</person-group> (<year>2007</year>). <article-title>Striatal function in generalized social phobia: A functional magnetic resonance imaging study</article-title>. <source>Biological Psychiatry</source>, <volume>61</volume>, <fpage>396</fpage>–<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr141-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schenberg</surname><given-names>E. E.</given-names></name>
<name><surname>Ferreira</surname><given-names>T. L.</given-names></name>
<name><surname>Figueredo</surname><given-names>L. Z. P.</given-names></name>
<name><surname>Hipólide</surname><given-names>D. C.</given-names></name>
<name><surname>Nobrega</surname><given-names>J. N.</given-names></name>
<name><surname>Oliveira</surname><given-names>M. G. M.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Fear conditioning performance and NMDA receptor subtypes: NR2A differential expression in the striatum</article-title>. <source>Brain Research Bulletin</source>, <volume>69</volume>, <fpage>440</fpage>–<lpage>446</lpage>.</citation>
</ref>
<ref id="bibr142-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schiller</surname><given-names>D.</given-names></name>
<name><surname>Levy</surname><given-names>I.</given-names></name>
<name><surname>Niv</surname><given-names>Y.</given-names></name>
<name><surname>Le Doux</surname><given-names>J. E.</given-names></name>
<name><surname>Phelps</surname><given-names>E. A.</given-names></name>
</person-group> (<year>2008</year>). <article-title>From fear to safety and back: Reversal of fear in the human brain</article-title>. <source>The Journal of Neuroscience</source>, <volume>28</volume>, <fpage>11517</fpage>–<lpage>11525</lpage>.</citation>
</ref>
<ref id="bibr143-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>P.</given-names></name>
<name><surname>Ho</surname><given-names>Y.-J.</given-names></name>
<name><surname>Spanagel</surname><given-names>R.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2011</year>). <article-title>A novel elevated plus-maze procedure to avoid the one-trial tolerance problem</article-title>. <source>Frontiers in Behavioral Neuroscience</source>, <volume>5</volume>, <fpage>43</fpage>, doi: 10.3389/fnbeh.2011.00043<pub-id pub-id-type="doi">10.3389/fnbeh.2011.00043</pub-id></citation>
</ref>
<ref id="bibr144-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>P.</given-names></name>
<name><surname>Spanagel</surname><given-names>R.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2009</year>). <article-title>Interleukin-2 affects social interaction behaviour in relation to anxiety-like trait behaviour in the elevated plus-maze in adult Wistar rats</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>23</volume>, <issue>Suppl. 1</issue>, <fpage>S19</fpage>.</citation>
</ref>
<ref id="bibr145-1754073911421374">
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Schneider</surname><given-names>P.</given-names></name>
<name><surname>Spanagel</surname><given-names>R.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2008</year>). <source>Individual behaviour and relationship between elevated plus-maze and social interaction test in adult rats</source>. <comment>Program No. 393. 2008 Abstract Viewer/Itinerary Planner</comment>. <conf-name>Poster presented at the Society for Neuroscience 38th Annual Meeting</conf-name>, <conf-loc>Washington, DC</conf-loc>. <comment>Abstract retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=8b033b4b-d7da-4b3a-b196-af4e05aa33bc&amp;cKey=4dbc1861-fe5c-4be1-874a-1e23ae995d27&amp;mKey=%7bAFEA068D-D012-4520-8E42-10E4D1AF7944%7d">http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=8b033b4b-d7da-4b3a-b196-af4e05aa33bc&amp;cKey=4dbc1861-fe5c-4be1-874a-1e23ae995d27&amp;mKey=%7bAFEA068D-D012-4520-8E42-10E4D1AF7944%7d</ext-link></comment></citation>
</ref>
<ref id="bibr146-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schoenbaum</surname><given-names>G.</given-names></name>
<name><surname>Setlow</surname><given-names>B.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Lesions of nucleus accumbens disrupt learning about aversive outcomes</article-title>. <source>The Journal of Neuroscience</source>, <volume>23</volume>, <fpage>9833</fpage>–<lpage>9841</lpage>.</citation>
</ref>
<ref id="bibr147-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwabe</surname><given-names>K.</given-names></name>
<name><surname>Klein</surname><given-names>S.</given-names></name>
<name><surname>Koch</surname><given-names>M.</given-names></name>
</person-group> (<year>2006</year>). <article-title>Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats</article-title>. <source>Behavioural Brain Research</source>, <volume>168</volume>, <fpage>150</fpage>–<lpage>160</lpage>.</citation>
</ref>
<ref id="bibr148-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Behavioral neuroscience in the rat: Taking the individual into account</article-title>. <source>Methods and Findings in Experimental and Clinical Pharmacology</source>, <volume>26</volume>, <issue>Suppl. 2</issue>, <fpage>17</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr149-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
<name><surname>Thiel</surname><given-names>C. M.</given-names></name>
<name><surname>Müller</surname><given-names>C. P.</given-names></name>
<name><surname>Huston</surname><given-names>J. P.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Relationship between anxiety and serotonin in the ventral striatum</article-title>. <source>Neuroreport</source>, <volume>9</volume>, <fpage>1025</fpage>–<lpage>1029</lpage>.</citation>
</ref>
<ref id="bibr150-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Silva</surname><given-names>R. C. B.</given-names></name>
<name><surname>Brandão</surname><given-names>M. L.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: An ethological analysis</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>65</volume>, <fpage>209</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr151-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smeets</surname><given-names>W. J. A. J.</given-names></name>
<name><surname>Marín</surname><given-names>O.</given-names></name>
<name><surname>González</surname><given-names>A.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Evolution of the basal ganglia: New perspectives through a comparative approach</article-title>. <source>Journal of Anatomy</source>, <volume>196</volume>, <fpage>501</fpage>–<lpage>517</lpage>.</citation>
</ref>
<ref id="bibr152-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steimer</surname><given-names>T.</given-names></name>
<name><surname>Driscoll</surname><given-names>P.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Divergent stress responses and coping styles in psychogenetically selected Roman high-(RLA) and low-(RLA) avoidance rats: Behavioural, neuroendocrine and developmental aspects</article-title>. <source>Stress</source>, <volume>6</volume>, <fpage>87</fpage>–<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr153-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Steimer</surname><given-names>T.</given-names></name>
<name><surname>Driscoll</surname><given-names>P.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Inter-individual vs line/strain differences in psychogenetically selected Roman high-(RHA) and low-(RLA) avoidance rats: Neuroendocrine and behavioural aspects</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>29</volume>, <fpage>99</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr154-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stein</surname><given-names>D. J.</given-names></name>
<name><surname>Stahl</surname><given-names>S.</given-names></name>
</person-group> (<year>2000</year>). <article-title>Serotonin and anxiety: Current models</article-title>. <source>International Clinical Psychopharmacology</source>, <volume>15</volume>, <issue>Suppl. 2</issue>, <fpage>S1</fpage>–<lpage>S6</lpage>.</citation>
</ref>
<ref id="bibr155-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strack</surname><given-names>F.</given-names></name>
<name><surname>Deutsch</surname><given-names>R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Reflective and impulsive determinants of social behavior</article-title>. <source>Personality and Social Psychology Review</source>, <volume>8</volume>, <fpage>220</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr156-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strelau</surname><given-names>J.</given-names></name>
</person-group> (<year>1997</year>). <article-title>The contribution of Pavlov’s typology of CNS properties to personality research</article-title>. <source>European Psychologist</source>, <volume>2</volume>, <fpage>125</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr157-1754073911421374">
<citation citation-type="other">
<person-group person-group-type="author">
<name><surname>Tellegen</surname><given-names>A.</given-names></name>
<name><surname>Waller</surname><given-names>N. G.</given-names></name>
</person-group> (<year>1992</year>). <source>Exploring personality through test construction: Development of the multidimensional personality questionnaire</source>. <comment>Unpublished manuscript</comment>, <publisher-name>University of Minnesota Press</publisher-name>.</citation>
</ref>
<ref id="bibr158-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thiel</surname><given-names>C. M.</given-names></name>
<name><surname>Müller</surname><given-names>C. P.</given-names></name>
<name><surname>Huston</surname><given-names>J. P.</given-names></name>
<name><surname>Schwarting</surname><given-names>R. K. W.</given-names></name>
</person-group> (<year>1999</year>). <article-title>High versus low reactivity to a novel environment: Behavioural, pharmacological and neurochemical assessments</article-title>. <source>Neuroscience</source>, <volume>93</volume>, <fpage>243</fpage>–<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr159-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tollefson</surname><given-names>G. D.</given-names></name>
<name><surname>Rosenbaum</surname><given-names>J. F.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Selective serotonin reuptake inhibitors</article-title>. In <person-group person-group-type="editor">
<name><surname>Schatzberg</surname><given-names>A. F.</given-names></name>
<name><surname>Nemeroff</surname><given-names>C. B.</given-names></name>
</person-group> (Eds.), <source>Textbook of psychopharmacology</source> (pp. <fpage>219</fpage>–<lpage>237</lpage>). <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Press</publisher-name>.</citation>
</ref>
<ref id="bibr160-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Treit</surname><given-names>D.</given-names></name>
</person-group> (<year>1985</year>). <article-title>Animal models for the study of anti-anxiety agents: A review</article-title>. <source>Neuroscience and Biobehavioral Reviews</source>, <volume>9</volume>, <fpage>203</fpage>–<lpage>222</lpage>.</citation>
</ref>
<ref id="bibr161-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Treit</surname><given-names>D.</given-names></name>
<name><surname>Menard</surname><given-names>J.</given-names></name>
<name><surname>Royan</surname><given-names>C.</given-names></name>
</person-group> (<year>1993</year>). <article-title>Anxiogenic stimuli in the elevated plus-maze</article-title>. <source>Pharmacology, Biochemistry and Behavior</source>, <volume>44</volume>, <fpage>463</fpage>–<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr162-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ueno</surname><given-names>K. I.</given-names></name>
<name><surname>Togashi</surname><given-names>H.</given-names></name>
<name><surname>Mori</surname><given-names>K.</given-names></name>
<name><surname>Matsumoto</surname><given-names>M.</given-names></name>
<name><surname>Ohashi</surname><given-names>S.</given-names></name>
<name><surname>Hoshino</surname><given-names>A.</given-names></name>
<name><surname>… Yoshioka</surname><given-names>M.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder</article-title>. <source>Behavioural Pharmacology</source>, <volume>13</volume>, <fpage>1</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr163-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van den Heuvel</surname><given-names>O. A.</given-names></name>
<name><surname>Veltman</surname><given-names>D. J.</given-names></name>
<name><surname>Groenewegen</surname><given-names>H. J.</given-names></name>
<name><surname>Cath</surname><given-names>D. C.</given-names></name>
<name><surname>van Balkom</surname><given-names>A. J. L. M.</given-names></name>
<name><surname>van Hartskamp</surname><given-names>J.</given-names></name>
<name><surname>van Dyck</surname><given-names>R.</given-names></name>
</person-group> (<year>2005a</year>). <article-title>Frontal-striatal dysfunction during planning in obsessive-compulsive disorder</article-title>. <source>Archives of General Psychiatry</source>, <volume>62</volume>, <fpage>301</fpage>–<lpage>310</lpage>.</citation>
</ref>
<ref id="bibr164-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van den Heuvel</surname><given-names>O. A.</given-names></name>
<name><surname>Veltman</surname><given-names>D. J.</given-names></name>
<name><surname>Groenewegen</surname><given-names>H. J.</given-names></name>
<name><surname>Witter</surname><given-names>M. P.</given-names></name>
<name><surname>Merkelbach</surname><given-names>J.</given-names></name>
<name><surname>Cath</surname><given-names>D. C.</given-names></name>
<name><surname>van Dyck</surname><given-names>R.</given-names></name>
</person-group> (<year>2005b</year>). <article-title>Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis</article-title>. <source>Archives of General Psychiatry</source>, <volume>62</volume>, <fpage>922</fpage>–<lpage>933</lpage>.</citation>
</ref>
<ref id="bibr165-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vyas</surname><given-names>A.</given-names></name>
<name><surname>Chattarji</surname><given-names>S.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Modulation of different states of anxiety-like behavior by chronic stress</article-title>. <source>Behavioral Neuroscience</source>, <volume>118</volume>, <fpage>1450</fpage>–<lpage>1454</lpage>.</citation>
</ref>
<ref id="bibr166-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wahlsten</surname><given-names>D.</given-names></name>
<name><surname>Metten</surname><given-names>P.</given-names></name>
<name><surname>Phillips</surname><given-names>T. J.</given-names></name>
<name><surname>Boehm</surname><given-names>S. L.</given-names><suffix>II</suffix></name>
<name><surname>Burkhart-Kasch</surname><given-names>S.</given-names></name>
<name><surname>Dorow</surname><given-names>J.</given-names></name>
<name><surname>… Crabbe</surname><given-names>J. C.</given-names></name>
</person-group> (<year>2003</year>). <article-title>Different data from different labs: Lessons from studies of gene–environment interaction</article-title>. <source>Journal of Neurobiology</source>, <volume>54</volume>, <fpage>283</fpage>–<lpage>311</lpage>.</citation>
</ref>
<ref id="bibr167-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walf</surname><given-names>A. A.</given-names></name>
<name><surname>Frye</surname><given-names>C. A.</given-names></name>
</person-group> (<year>2007</year>). <article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title>. <source>Nature Protocols</source>, <volume>2</volume>, <fpage>322</fpage>–<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr168-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weintraub</surname><given-names>D.</given-names></name>
<name><surname>Newberg</surname><given-names>A. B.</given-names></name>
<name><surname>Cary</surname><given-names>M. S.</given-names></name>
<name><surname>Siderowf</surname><given-names>A. D.</given-names></name>
<name><surname>Moberg</surname><given-names>P. J.</given-names></name>
<name><surname>Kleiner-Fisman</surname><given-names>G.</given-names></name>
<name><surname>… Katz</surname><given-names>I. R.</given-names></name>
</person-group> (<year>2005</year>). <article-title>Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease</article-title>. <source>The Journal of Nuclear Medicine</source>, <volume>46</volume>, <fpage>227</fpage>–<lpage>232</lpage>.</citation>
</ref>
<ref id="bibr169-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>S. M.</given-names></name>
<name><surname>Wadsworth</surname><given-names>G.</given-names></name>
<name><surname>Fletcher</surname><given-names>A.</given-names></name>
<name><surname>Dourish</surname><given-names>C. T.</given-names></name>
</person-group> (<year>1998</year>). <article-title>Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety</article-title>. <source>Neuroscience &amp; Biobehavioral Reviews</source>, <volume>23</volume>, <fpage>265</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr170-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wichers</surname><given-names>M.</given-names></name>
<name><surname>Maes</surname><given-names>M.</given-names></name>
</person-group> (<year>2002</year>). <article-title>The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans</article-title>. <source>International Journal of Neuropsychopharmacology</source>, <volume>5</volume>, <fpage>375</fpage>–<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr171-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wigger</surname><given-names>A.</given-names></name>
<name><surname>Sánchez</surname><given-names>M. M.</given-names></name>
<name><surname>Mathys</surname><given-names>K. C.</given-names></name>
<name><surname>Ebner</surname><given-names>K.</given-names></name>
<name><surname>Frank</surname><given-names>E.</given-names></name>
<name><surname>Liu</surname><given-names>D.</given-names></name>
<name><surname>… Landgraf</surname><given-names>R.</given-names></name>
</person-group> (<year>2004</year>). <article-title>Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: Critical role of vasopressin</article-title>. <source>Neuropsychopharmacology</source>, <volume>29</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr172-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willner</surname><given-names>P.</given-names></name>
</person-group> (<year>1984</year>). <article-title>The validity of animal models of depression</article-title>. <source>Psychopharmacology</source>, <volume>83</volume>, <fpage>1</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr173-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Willner</surname><given-names>P.</given-names></name>
</person-group> (<year>1986</year>). <article-title>Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case</article-title>. <source>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</source>, <volume>10</volume>, <fpage>677</fpage>–<lpage>690</lpage>.</citation>
</ref>
<ref id="bibr174-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Willner</surname><given-names>P.</given-names></name>
</person-group> (<year>1991</year>). <article-title>Behavioural models in psychopharmacology</article-title>. In <person-group person-group-type="editor">
<name><surname>Willner</surname><given-names>P.</given-names></name>
</person-group> (Ed.), <source>Behavioural models in psychopharmacology: Theoretical, industrial and clinical perspectives</source> (pp. <fpage>3</fpage>–<lpage>18</lpage>). <publisher-loc>Cambridge, UK</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>.</citation>
</ref>
<ref id="bibr175-1754073911421374">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Willner</surname><given-names>P.</given-names></name>
<name><surname>Mitchell</surname><given-names>P. J.</given-names></name>
</person-group> (<year>2002</year>). <article-title>Animal models of depression: A diathesis/stress approach</article-title>. In <person-group person-group-type="editor">
<name><surname>D’Haenen</surname><given-names>H.</given-names></name>
<name><surname>den Boer</surname><given-names>J. A.</given-names></name>
<name><surname>Willner</surname><given-names>P.</given-names></name>
</person-group> (Eds.), <source>Biological psychiatry</source> (pp. <fpage>703</fpage>–<lpage>726</lpage>). <publisher-loc>Chichester, UK</publisher-loc>: <publisher-name>Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr176-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woodcock</surname><given-names>J.</given-names></name>
</person-group> (<year>2007</year>). <article-title>The prospects for “personalized medicine” in drug development and drug therapy</article-title>. <source>Journal of Clinical Pharmacy and Therapeutics</source>, <volume>81</volume>, <fpage>164</fpage>–<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr177-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>J. C.</given-names></name>
<name><surname>Buchsbaum</surname><given-names>M. S.</given-names></name>
<name><surname>Hershey</surname><given-names>T. G.</given-names></name>
<name><surname>Hazlett</surname><given-names>E.</given-names></name>
<name><surname>Sicotte</surname><given-names>N.</given-names></name>
<name><surname>Johnson</surname><given-names>J. C.</given-names></name>
</person-group> (<year>1991</year>). <article-title>PET in generalized anxiety disorder</article-title>. <source>Biological Psychiatry</source>, <volume>29</volume>, <fpage>1181</fpage>–<lpage>1199</lpage>.</citation>
</ref>
<ref id="bibr178-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>S. L.</given-names></name>
<name><surname>Hsu</surname><given-names>L. S.</given-names></name>
<name><surname>Tu</surname><given-names>W. T.</given-names></name>
<name><surname>Wang</surname><given-names>W. F.</given-names></name>
<name><surname>Huang</surname><given-names>Y. T.</given-names></name>
<name><surname>Pawlak</surname><given-names>C. R.</given-names></name>
<name><surname>Ho</surname><given-names>Y. J.</given-names></name>
</person-group> (<year>2008</year>). <article-title>Effects of d-cycloserine on the behavior and ERK activity in the amygdala: Role of individual anxiety levels</article-title>. <source>Behavioural Brain Research</source>, <volume>187</volume>, <fpage>246</fpage>–<lpage>253</lpage>.</citation>
</ref>
<ref id="bibr179-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yehuda</surname><given-names>R.</given-names></name>
<name><surname>Hyman</surname><given-names>S. E.</given-names></name>
</person-group> (<year>2005</year>). <article-title>The impact of terrorism on brain, and behavior: What we know and what we need to know</article-title>. <source>Neuropsychopharmacology</source>, <volume>30</volume>, <fpage>1773</fpage>–<lpage>1780</lpage>.</citation>
</ref>
<ref id="bibr180-1754073911421374">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yerkes</surname><given-names>R. M.</given-names></name>
<name><surname>Yerkes</surname><given-names>A. W.</given-names></name>
</person-group> (<year>1936</year>). <article-title>Nature and conditions of avoidance (fear) responses in chimpanzees</article-title>. <source>Journal of Comparative Psychology</source>, <volume>21</volume>, <fpage>53</fpage>–<lpage>66</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>